Summary of findings for the main comparison
===========================================

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------- ------------------------------------------------------ ------------------------------------- ----------------------------------------------------- --------------------------------------------------------------------------------------- --
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  **Patient or population:** children \< 5 years of age\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  **Settings:** middle- and low-income countries\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
  **Intervention:** integrated management of childhood illness\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
  **Comparison:** usual health services                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  **Outcomes**                                                                                                                                                                                                                                              **Illustrative comparative risks\* (95% CI)**   **Relative effect(95% CI)**                            **Number of participants(studies)**   **Certainty of the evidence(GRADE)**                  **Comments**                                                                            

                                                                                                                                                                                                                                                            **Assumed risk**                                **Corresponding risk**                                                                                                                                                                                                                     

                                                                                                                                                                                                                                                            **Control**                                     **IMCI**                                                                                                                                                                                                                                   

  **Mortality**                                                                                                                                                                                                                                             **Child mortality**                             **Risk ratio 0.87**^a^\                                5090 children\                        ⊕⊕◯◯\                                                 Child mortality may be decreased, but confidence intervals include no effect            
                                                                                                                                                                                                                                                                                                            (0.68 to 1.10)                                         (1 trial)^1^                          **Low**\                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                         ^b,c^\                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                         due to indirectness and imprecision                                                                                                           

                                                                                                                                                                                                                                                            **31 per 1000 live births**                     **27 per 1000 live births**\                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                            (21 to 34)                                                                                                                                                                                                                                 

                                                                                                                                                                                                                                                            **Infant mortality**                            **HR 0.85**\                                           60,480^e^\                            ⊕⊕◯◯\                                                 Infant mortality may decrease                                                           
                                                                                                                                                                                                                                                                                                            (0.77 to 0.94)                                         (1 trial) ^2^                         **Low**\                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                         ^f,g,h^\                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                         due to indirectness and imprecision                                                                                                           

                                                                                                                                                                                                                                                            **69 per 1000 live births**                     **59 per 1000 live births**\                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                            (54 to 65)^d^                                                                                                                                                                                                                              

  **Nutritional status**                                                                                                                                                                                                                                    **Stunting**                                    **Risk ratio 0.94**\                                   5242\                                 ⊕⊕◯◯\                                                 Little or no effect on stunting possible                                                
                                                                                                                                                                                                                                                                                                            ^i^\                                                   (2 trials) ^1,2^                      **Low**\                                                                                                                                      
                                                                                                                                                                                                                                                                                                            ^(0.84\ to\ 1.06)^                                                                           ^b,f,j^\                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                         due to indirectness and imprecision                                                                                                           

                                                                                                                                                                                                                                                            **57 per 100**                                  **53 per 100**\                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                            (48 to 60)                                                                                                                                                                                                                                 

                                                                                                                                                                                                                                                            **Wasting**                                     **Risk ratio 1.04**\                                   4288\                                 ⊕⊕⊕◯\                                                 Probably little or no effect on wasting                                                 
                                                                                                                                                                                                                                                                                                            ^i^\                                                   (2 trials) ^1,2^                      **Moderate**\                                                                                                                                 
                                                                                                                                                                                                                                                                                                            (0.87 to 1.25)                                                                               ^b,j^\                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                         due to indirectness                                                                                                                           

                                                                                                                                                                                                                                                            **13 per 100**                                  **14 per 100**\                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                            (11 to 16)                                                                                                                                                                                                                                 

  **Quality of care**                                                                                                                                                                                                                                       **Prescribing at health facilities**            Mixed effects^k^                                       727\                                  ⊕◯◯◯\                                                 Not known whether consistent effect on prescribing quality at health facilities         
                                                                                                                                                                                                                                                                                                                                                                   (2 studies)^1,3^                      **Very low**\                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                         ^l,m^\                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                         due to imprecision, inconsistency, and indirectness                                                                                           

                                                                                                                                                                                                                                                            **Prescribing by lay health care workers**      No consistent effects                                  1051 observations\                    ⊕◯◯◯\                                                 Not known whether consistent effect on prescribing quality of lay health care workers   
                                                                                                                                                                                                                                                                                                                                                                   (3 studies)^1,3,4^                    **Very low**\                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                         ^l,m^\                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                         due to imprecision, inconsistency, and indirectness                                                                                           

  **Coverage of IMCI deliverables**                                                                                                                                                                                                                         **Vaccine coverage (measles)**                  **RR 0.92**\                                           4895\                                 ⊕⊕⊕◯\                                                 Probably little or no effect on measles vaccine coverage^n^                             
                                                                                                                                                                                                                                                                                                            (0.80 to 1.05)                                         (2 trials) ^1,2^                      **Moderate**\                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                         ^n,j^\                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                         due to indirectness                                                                                                                           

                                                                                                                                                                                                                                                            **57/100**                                      **54/100**\                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                            (46 to 60)                                                                                                                                                                                                                                 

                                                                                                                                                                                                                                                            **Supplement coverage (vit A)**                 **RR 0.93**\                                           831\                                  ⊕⊕⊕◯\                                                 Probably little or no effect on vitamin A coverage                                      
                                                                                                                                                                                                                                                                                                            (0.88 to 0.98)                                         (1 trial)^1^                          **moderate**\                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                         ^n,j^\                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                         due to indirectness                                                                                                                           

                                                                                                                                                                                                                                                            **83 per 100**                                  **77 per 100**\                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                            (73 to 81)                                                                                                                                                                                                                                 

                                                                                                                                                                                                                                                            **Appropriate care seeking**                    Mixed effects^o^                                       4182\                                 ⊕⊕◯◯\                                                 Appropriate care seeking possibly improved in some studies, but not in others           
                                                                                                                                                                                                                                                                                                                                                                   (3 studies)^1,2,3^                    **Low**\                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                         ^p^\                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                         due to inconsistency                                                                                                                          

                                                                                                                                                                                                                                                            **Exclusive breast feeding**                    Mixed effects^q^                                       7975\                                 ⊕◯◯◯\                                                 Not known whether effect on exclusive breast feeding                                    
                                                                                                                                                                                                                                                                                                                                                                   (4 studies) ^1,2,3,4^                 **Very low**\                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                         ^p,r,s,t,u^\                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                         due to indirectness and inconsistency                                                                                                         

  **Satisfaction of beneficiaries**                                                                                                                                                                                                                         Not measured                                    Not known whether users prefer IMCI or usual clinics                                                                                                                                                                                       

  The basis for **assumed risk** is median control group risk across studies. The **corresponding risk** (and its 95% confidence interval) is based on assumed risk in the comparison group and **relative effect** of the intervention (and its 95% CI)\                                                                                                                                                                                                                                                                                              
  **CI:** confidence interval; **ICC:** intracluster correlation co-efficient; **RR:** risk ratio                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  GRADE Working Group grades of evidence\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  **High certainty:** We are very confident that the true effect lies close to the estimate of effect\                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  **Moderate certainty:** We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of effect but may be substantially different\                                                                                                                                                                                                                                                                                                                                                                      
  **Low certainty:** Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of effect\                                                                                                                                                                                                                                                                                                                                                                                                     
  **Very low certainty:** We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect.                                                                                                                                                                                                                                                                                                                                                                                  
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------- ------------------------------------------------------ ------------------------------------- ----------------------------------------------------- --------------------------------------------------------------------------------------- --

^a^In the Bangladesh trial, mortality declined over the 5 years from 43 per 1000 live births to 27 per 1000 live births in the intervention area (reduced by 37%), and from 44.8 per 1000 live births to 31.2 per 1000 live births in control areas (reduced by 30%). A small difference in the reduction in child mortality was noted in the 2 groups (8.6% in the intervention group vs 7.8% in control groups).

The Tanzanzia CBA study had mortality estimates that were very similar to the Bangladesh trial (RR 0.87, 95%CI 0.72 to 1.05).

^b^Downgraded by 1 for serious indirectness: The Bangladesh trial modified the intervention after early analysis for care seeking and referral completion, suggesting that coverage was not increasing as expected. This included modification of treatment and referral guidelines and introduction of a new cadre of village health care workers trained and equipped to provide community case management for pneumonia and diarrhoea in 2005. These adjustments, including the new staff cadre, were in response to an intermediate process evaluation in the trial, and are unlikely to be mirrored in routine implementation programmes.

^c^Downgraded by 1 for imprecision: 95% CI is wide and includes a clinically important reduction in mortality and no effect. In addition, dominant change was secular (see note 1)

^d^Absolute rates were calculated from hazard ratio by using the formula *RR = (1 - exp(HR* ×*ln(1 - assumed risk)))/assumed risk*

^e^IMCI in this trial included perinatal and neonatal components

^f^Downgraded for serious imprecision. Confidence intervals include no important effect to an important effect

^g^Downgraded by 1 for serious indirectness: This single study was conducted in a mixed rural/urban population in northern India with a substantive neonatal component with home visiting. Findings may not be easily generalized to other settings in Asia or elsewhere

^h^Subgroup analysis showed lower mortality in the intervention group among babies delivered at home, with no effect apparent in the subgroup delivering at hospital. This subgroup effect was evident for both neonatal and infant mortality

^i^Confidence intervals for Arifeen adjusted assuming ICC of 0.01

^j^ The Tanzania CBA study has very similar estimates compatible with this estimate

^k^Large improvements in 6 parameters in Arifeen; no clear effect in 2 parameters in Schellenberg

^l^Downgraded by 1 for both imprecision and inconsistency. Small numbers of participants observed; effect varies between trials and parameters measured

^m^Downgraded by 1 for indirectness. All measurements through direct observation of health care worker; may not represent behavior unobserved

^n^Downgraded by 1 for indirectness. Approximately 80% of the estimate taken from 1 study, so generalisability to other settings is uncertain

^o^Point estimate for vaccine coverage suggests higher coverage in control group, and 95% confidence intervals exclude beneficial effect of IMCI on coverage.

^p^This outcome was measured in various ways by different studies on samples of patients. Large improvements noted in some studies but not in others. As the outcome was so varied, we did not prepare a meta-analysis

^q^Downgraded by 2 for inconsistency. Some large effects in some studies, and modest/no effects in others

^r^Mixed effects between the 4 studies preclude meta-analysis

^s^Downgraded by 2 for inconsistency. Large amounts of qualitative heterogeneity

^t^Downgraded by 1 for indirectness. See (b) above and the large effects seen in Bhandari associated with several home visits, which would not be feasible in other settings

^u^Downgraded by 1 for risk of bias. Breast feeding was reported through questionnaire from health care workers to mothers

Studies

^1^ Arifeen 2009;^2^ Bhandari 2012; ^3^ Schellenberg 2004 ; ^4^ Mohan 2011

Background
==========

Description of the condition
----------------------------

More than 7.5 million children globally die each year before reaching the age of five. Most of these deaths occur in low- and middle-income countries (LMICs) (Black [@b58]; Liu [@b69]), where interaction of common infections (including neonatal sepsis, measles, diarrhoea, malaria, and pneumonia) with poor nutritional status, combined with inadequate health infrastructure and poverty, results in poor health outcomes (Liu [@b69]; Tulloch [@b77]). Statistical projections over the past decade suggest that these common childhood illnesses will continue to be major contributors to the child morbidity and mortality burden until 2020 (Murray [@b72]). These projections have been uncannily accurate, as shown by recent mortality data (WHO [@b86]), providing a strong case for introducing new strategies to tackle problems contributing to poor outcomes.

In addition to overall high child mortality globally, there are large differences in mortality between countries, with earlier studies indicating that 95% of global mortality happens in 42 less-developed countries (Victora [@b78]); there are also differences in mortality between socio-economic groups within countries. Children who belong to the more underprivileged sections of society are more likely to suffer from malnutrition and to experience greater severity of illness and higher mortality (Black [@b58]; Victora [@b78]). These inequalities are reflected in the quality of health care received. Studies have shown that at first-level health facilities in LMICs, assessment by health care workers is poor, treatment facilities are inadequate, and parents receive improper advice (Barros [@b56]; World [@b89]).

Providing quality care to sick children in LMICs is important. Effective and affordable interventions have been known to reduce childhood morbidity and mortality for some time, but their availability, accessibility, and acceptability to the ultimate beneficiaries have been unacceptably low (Bryce [@b59]; Jones [@b67]).

Description of the intervention
-------------------------------

Individual health interventions shown to be effective in reducing child mortality include exclusive breast feeding, improved vaccination coverage, oral rehydration therapy, pneumonia therapy, and early treatment for malaria in endemic areas (Bhutta [@b57]; Markowitz [@b70]; Mathew [@b71]; Thwing [@b76]). However, children presenting to first-level health facilities seldom present with a single ailment. The presence of multiple and overlapping morbidities makes diagnosis and treatment difficult for the health care worker. Although each of these interventions has been individually shown to be effective, it has gradually become clear to health care planners that a more integrated approach is needed to achieve better outcomes. This has resulted in a policy push toward a multi-pronged strategy aimed at integrating improved health care services with better case management skills and healthier community practices to reduce child mortality and morbidity (WHO [@b79]). Health care packages that aim to integrate these components of health care strategy have been designed and implemented at community, national, and international levels. In the mid-1990s, the World Health Organization (WHO), in collaboration with the United Nations Children\'s Emergency Fund (UNICEF) and other agencies, developed a strategy known as integrated management of childhood illness (IMCI) in response to these challenges.

The IMCI strategy includes both curative and preventive interventions targeted at improving health practices at health care facilities, at home, and in the community. This strategy includes three main components (Tulloch [@b77]): (1) improvement in the case management skills of health care staff through provision of locally adapted guidelines on IMCI and activities to promote their use; (2) improvement in the overall health care system required for effective management of childhood illnesses; and (3) improvement in family and community health care practices.

In 1995, WHO technical programs and partners, supported by sound research, introduced case management guidelines for IMCI (WHO [@b80]), with a core intervention targeting five of the most important causes of child mortality: acute respiratory infection (ARI), diarrhoea, measles, malaria, and malnutrition. The following year, a training program was targeted at first-level health care workers. These case management guidelines were adapted to local epidemiology and clinical practice, and training of the first health care workers started in 1995. This was followed by a short period of exploratory implementation and documentation in a small number of countries (Lambrechts [@b68]). After an initial pilot phase, IMCI was introduced in Tanzania and Uganda in 1996 (Bryce [@b60]). Results from these two countries were encouraging, with improvements noted in quality of care and health care worker practices (Lambrechts [@b68]). In the early phase of its implementation, IMCI was focused on training health care workers, with less attention paid to the other two components, namely, strengthening health care systems and improving community practices. Initial guidelines and training materials were considered appropriate for countries with an infant mortality rate greater than 40/1000 live births, and with documented transmission of *Plasmodium falciparum* malaria. The guidelines and training materials represented an attempt to outline what needed to be done at a first-level health facility by any health worker - doctor, nurse, or paramedical worker - seeking to treat sick children while reducing mortality.

Upon receipt of an encouraging response from partner organizations, various countries, and the World Bank, the WHO provided a detailed blueprint of a three-phase rollout for countries wishing to adopt IMCI (WHO [@b82]). The process consisted of the introduction phase, the early implementation phase, and the expansion phase. The purpose of the introduction phase is to ensure that policymakers understand IMCI. This involves initiating contact to provide information, holding orientation meetings, and building national capacity in IMCI. In the early implementation phase, health care staff conduct and monitor IMCI activities in a limited number of districts to study impact. Other issues studied during this phase include the relationship of IMCI to other health care sector activities, drug availability, and policy and supervision. The expansion phase involves increasing access to interventions introduced in the first two stages. The WHO and collaborating agencies provide technical assistance in preparation for early implementation of IMCI.

Anecdotal data, qualitative reviews, and systematic reviews from various countries suggest that IMCI has been effective in improving health service quality and increasing health care cost savings (Ahmad [@b54]; Amaral [@b55]). Since its introduction, IMCI has been taken up by numerous countries, initially as a pilot project, and later as a national program. The three components of IMCI have been implemented in various ways in different countries. Key features of IMCI include its evidence-based approach to diagnosis and treatment and its flexibility in terms of adapting guidelines to local epidemiological situations. The adaptation process involves detailed comparisons of existing guidelines in a country with IMCI and application of the most effective components of both. Consensus is needed on the conditions that should be covered. Malaria can be removed from guidelines in which falciparum malaria is not a problem. Other countries have included dengue fever as an important problem. IMCI has already been adapted to include the neonatal period, and some countries, like India, have incorporated neonatal care in implementation of the program. Selection of antibiotics for ARI and diarrhoea is based on local sensitivity patterns and availability. Some countries have shortened the duration of training to reduce costs. In many countries, especially in sub-Saharan Africa, HIV/AIDS contributes significantly to child morbidity and mortality, resulting in the need to include specific assessment and management of symptomatic HIV infection in IMCI guidelines. A draft HIV component of the IMCI guidelines, which included management of symptomatic HIV cases with referral for counselling and testing, was evaluated in South Africa. A revised version was then validated in Ethiopia and Uganda, where prevalence of HIV, malnutrition, and malaria is different from South Africa. IMCI materials were then adapted to include an HIV component (Qazi [@b74]). The WHO has formulated an Adaptation Guide to describe the process of adaptation by a country and facilitate continuous evolution of the program (WHO [@b83]).

Large-scale rollout and continuation of IMCI require money. In several countries, external donors have largely funded IMCI implementation. Within 10 years, donor support began to wane, leaving health departments of poor countries with inadequate funds (Duke [@b61]). Indeed the places where IMCI is needed most, and in which it provides the greatest impact, are those in which the health care system is weakest and implementation of the strategy often fades. Therefore, it is important to ensure adequate development along with the introduction of newer innovations. A global study conducted across 27 countries cited high cost as a major challenge to scaling up of the program (Goga [@b63]). Apart from modifications such as shortening of training duration, new technology such as the IMCI computerized adaptation and training tool (ICATT) is being introduced. Trials are currently under way to assess the effectiveness of these tools.

How the intervention might work
-------------------------------

The IMCI clinical guidelines target children up to five years of age - the age group that bears the greatest burden of death from common childhood diseases. These guidelines are derived from an evidence-based, syndromic approach to case management and emphasize rational, effective, and affordable use of drugs and diagnostic tools (Gove [@b64]; Hill [@b66]). With well-formulated guidelines and proper training of health care workers, it would be possible to systematically assess common symptoms and clinical signs, ultimately leading to rational and effective actions. Such an approach can help in diagnosing the clinical condition, assessing the severity of the condition, and implementing actions that can be taken to care for the child (e.g. refer the child immediately, manage within available resources, manage at home).

Initially, IMCI referred to case management of children. It later became a vehicle for WHO and UNICEF child survival strategies at household, community, health facility, and referral levels. Thus it incorporated health service strengthening on the one hand and, on the other hand, face-to-face nutrition and health advice provided through home visits and active involvement of family members and the community in the health care process (Gove [@b64]; Hill [@b66]). Thus, over the years, implementation of IMCI, called the IMCI strategy, has come to include three components.

Training component: training of health care workers in clinical care with the use of IMCI guidelines.Systems component: investment in health care systems organization and management, including supplies, related specifically to delivery of IMCI.Community health component: Auxiliary health care staff and community health care workers attached to clinics conduct home visits and community health promotion to promote good child rearing practices, good nutrition, and access to services when the child is ill (Hill [@b66]).

Why it is important to do this review
-------------------------------------

Currently, more than 75 countries are implementing the IMCI strategy on a large scale. For years, individual aspects of child health, often contained within trials evaluating the efficacy of one intervention, have been carried out, for example, in vitamin A supplementation. Individual components of IMCI have often been tested and have proved effective in rigorously conducted randomised controlled trials and systematic reviews. However, it is unclear whether delivery of this package impacts hard outcomes such as mortality. As provision of IMCI is expensive, solid evidence of an impact on child health contributes to continued provision of political and financial support of this comprehensive child health strategy.

Global evaluation of IMCI, called \"the multi-country evaluation of IMCI,\" was started in the early 1990s to generate information on effectiveness, cost, and impact, alongside other initiatives, such as the IMCI evaluation by the Centers for Disease Control and Prevention (CDC) (Schellenberg [@b4]); investigators reported across five study sites (WHO [@b84]). Other reviews have described health care worker performance as the primary outcome indicator (Amaral [@b55]) or have assessed the impact of the duration of training for IMCI (Rowe [@b75]), thereby not analysing the impact of the intervention on beneficiaries. A comprehensive systematic review is therefore required to evaluate the effectiveness of IMCI in improving child health (as measured by mortality or nutritional status), its impact on the quality of care delivered, and whether basic healthy practices delivered by caregivers improve.

Objectives
==========

To evaluate the effects of programs that implement the integrated management of childhood illnesses (IMCI) strategy in terms of death, nutritional status, quality of care, coverage with IMCI deliverables, and satisfaction of beneficiaries.

Methods
=======

Criteria for considering studies for this review
------------------------------------------------

### Types of studies

Randomised controlled trials, including cluster-randomised trials.

Non-randomised trials with a concurrent comparison group (no IMCI intervention) and adjustment for baseline characteristics and confounders.

Controlled before-after (CBA) studies in which allocation to different comparison groups was not made by study investigators, and outcomes were measured in both intervention and control groups at baseline and after the IMCI program had been introduced.

All studies required at least two intervention sites and at least two control sites.

### Types of participants

The unit of study was primary health care services in low- and middle-income countries (as categorized by The World Bank using gross national income per capita in US dollars and the Atlas conversion factor (World [@b88])). This could be provided by the public, private, or non-government agency sector.

Participants were children younger than five years of age and health care providers in low- and middle-income countries (as categorized by The World Bank using gross national income per capita in US dollars and the Atlas conversion factor ([World Bank 2012](http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD010123/full#CD010123-bbs2-0041))).

### Types of interventions

Children younger than five years of age allocated to receive the generic WHO/UNICEF IMCI intervention or its adaptation. To be included, the IMCI intervention needed to include improving health care worker skills for case management as one component.

We included studies of (1) IMCI training alone; (2) IMCI training plus systems interventions to improve care delivery; (3) IMCI training with additional activities to improve community health practices; and (4) all three interventions.

We excluded studies that included IMCI only as a part of a wider intervention package that could include conditional cash transfers, food supplementation, employment, and vertical disease-specific measures.

Studies providing specific additional interventions in both intervention and control areas were eligible for inclusion as long as these additional interventions were similar across intervention and control areas.

### Comparison

We included studies in which the comparison group received usual health services without the integrated health care package (IMCI).

### Types of outcome measures

Measures of mortality (neonatal, infant, and under-five mortality) rates.Measures of nutritional status, including stunting and wasting.Quality of care assessed by adherence to standard practice guidelines.Coverage of key IMCI deliverables, including (1) vaccine coverage; (2) appropriate care seeking for common illnesses; and (3) exclusive breast feeding.Satisfaction of beneficiaries.

As one study also reported on other newborn care practices, which we did not anticipate, we describe these results under \"coverage.\" In addition, in the protocol, we stated that we would assess morbidity episodes as secondary outcomes. As it is unlikely that IMCI would influence the incidence of disease, and studies did not report on this, we have not commented further on this outcome.

Search methods for identification of studies
--------------------------------------------

### Electronic searches

We attempted to identify all relevant trials irrespective of language or publication status. We used the search term \"IMCI\" OR \"IMNCI\" OR \"integrated management of childhood illness\" across various databases. A more complex search strategy was not needed, as \"IMCI\" does not have a corresponding medical subject heading (MeSH) term, and all papers that consider IMCI use this term in the title, abstract, or text.

We (TG and DS) searched the following databases using the strategy described above.

Cochrane Central Register of Controlled Trials (CENTRAL) (www.cochranelibrary.com), including the Cochrane Effective Practice and Organisation of Care (EPOC) Group Specialised Register (searched 30 June 2015).MEDLINE (1946 to date), Ovid (searched 30 June 2015).EMBASE (1980 to date), Ovid (searched 30 June 2015).Cumulative Index to Nursing and Allied Health Literature (CINAHL) Plus (2000 to date), EbscoHost (searched 30 June 2015).Latin American Caribbean Health Sciences Literature (LILACS), Virtual Health Library (VHL) (searched 30 June 2015).World Health Organization (WHO) Library & Information Networks for Knowledge Database (WHOLIS) (searched 30 June 2015).Science Citation Index and Social Sciences Citation Index, Institute for Scientific Information (ISI) Web of Science (1950 to present) (searched 30 June 2015).Population Information Online (POPLINE) (searched 30 June 2015).World Health Organization (WHO) International Clinical Trials Registry Platform (WHO ICTRP) (searched 30 June 2015).Global Health (1973 to 2016 Week 17), OvidSP (searched 08 May 2016).Health Management (1986 to present), ProQuest (searched to 17 December 2012. We did not have access to this database after this date).

We have listed in [Appendix 1](#sec1){ref-type="sec"} search strategies used for the various databases and the number of trials identified.

### Searching other resources

We scanned the reference lists of all included papers and relevant reviews to identify citations that could have been missed in the primary search. We contacted authors of other relevant reviews in the field regarding relevant studies of which they were aware.

Data collection and analysis
----------------------------

### Selection of studies

Two review authors (TG and DS) removed duplicate records, then independently scanned the titles and abstracts of studies identified in the computerized search to exclude literature that clearly did not meet the inclusion criteria. We examined full-text articles against eligibility criteria while using a structured form. We resolved uncertainties about inclusion by discussion and consensus between all review authors. Controlled before-after studies were required to include at least two control groups and at least two intervention groups, as otherwise differences detected are totally confounded by study site.

### Data extraction and management

Two review authors (TG and DS) used a structured form to independently extract relevant data, including details of methods, participants, setting, context, interventions, outcomes and results, publications, and investigators. We resolved discrepancies by mutual discussion. When discrepancies could not be resolved, we sought assistance from a third review authors (HSS).

We described the IMCI strategy by using a matrix to detail inputs and activities. This matrix includes (1) training inputs; (2) tools and manuals, including guidelines; (3) additional equipment and drugs provided; (4) managerial supervision and monitoring, including additional health information collected; and (5) engagement, training, and support of community volunteers, as well as health care providers involved in the program. We intended to stratify the analysis to reflect inputs (separating simple training; training and systems support; training and community engagement; and training, systems support, and community engagement) but found that data were insufficient.

### Assessment of risk of bias in included studies

Two review authors (TG and DS) independently assessed the risk of bias for each controlled trial and controlled before-after study using criteria outlined in the *Cochrane Handbook for Systematic Reviews of Interventions* and those recommended by EPOC (EPOC [@b62]; Higgins [@b65]). For randomised controlled trials, non-randomised controlled trials, and CBA studies, these criteria include the following.

Sequence generation (selection bias).Allocation sequence concealment (selection bias). Blinding of participants and personnel (performance bias).Blinding of outcome assessment (detection bias).Incomplete outcome data (attrition bias).Selective outcome reporting (reporting bias).Comparability of baseline outcome and characteristics.Protection from contamination.Other potential sources of bias.

For cluster-randomised trials, particular biases to consider include the following.

Recruitment bias.Baseline imbalance.Loss of clusters.Incorrect analysis.

We omitted \"comparability with individually randomised trials\", as this intervention could be tested only in the context of a cluster trial (Higgins [@b65]).

The judgment for each entry involves assessing risk of bias as \"low,\" \"high,\" or \"unclear,\" with the last category indicating lack of information or uncertainty over the potential for bias. We resolved disagreements by discussion between review authors.

### Measures of treatment effect

We expressed results as risk ratios (RRs) with 95% confidence intervals (CIs) for binary outcomes. We analysed continuous outcomes using mean differences (MDs).

### Unit of analysis issues

When a cluster-randomised trial was adjusted for clustering, we extracted cluster-adjusted results and used them in analyses.

When a cluster-randomised trial did not adjust for clustering, we extracted unadjusted results. As we were not able to obtain an estimate of intracluster correlation co-efficients (ICCs) from the trials themselves, we used sensitivity analyses and an estimated ICC of 0.01 to investigate the impact of clustering on estimates of effectiveness.

### Dealing with missing data

We anticipated that we would need to impute values to estimate cluster effects, but this was not required.

### Assessment of heterogeneity

We described the context in which the intervention was implemented. We described in the table of included studies variability among participants, interventions, and outcomes studied.

Statistical heterogeneity was to be identified and measured as recommended by the *Cochrane Handbook for Systematic Reviews of Interventions* (Section 9.5.2) (Higgins [@b65]). As we found so few studies, we were careful about conducting meta-analysis and carried this out only when it made sense to do so. If heterogeneity based on Chi^2^ was assessed as greater than 50%, we used a random-effects model and interpreted results carefully.

### Assessment of reporting biases

We anticipated using funnel plots to examine for publication bias but found insufficient trials to do this.

### Data synthesis

Overall, the review provides a structured synthesis. When meta-analysis made sense, we used Review Manager software (RevMan 5.3), expressing results as risk ratios with 95% confidence intervals, or mean differences, as applicable. We used CBA results alongside the trials results, but did not combine them statistically. We assessed the certainty of the evidence by using the GRADE approach and summarized key findings in [Table 1](#tbl1){ref-type="table"}.

### Subgroup analysis and investigation of heterogeneity

Our planned subgroup analyses were not possible, as data were insufficient.

Results
=======

Description of studies
----------------------

### Results of the search

Searches of various databases yielded 1499 records to be screened, after duplicates were deleted. Of these, we found 1433 irrelevant to the review on screening. We obtained full texts of the remaining 50 studies, reported in 66 publications. Of these, four studies (two cluster RCTs and two CBA studies) described in 12 articles met our inclusion criteria ([1](#fig1){ref-type="fig"}). We reported reasons for excluding studies in the Characteristics of excluded studies table. We identified one trial through other sources in May 2016 (Boone [@b53]). We included this study amongst Studies awaiting classification and will consider it in an update in due course.

![Study flow diagram.](CD010123-0001-f01){#fig1}

### Included studies

#### Locations and populations

Studies were conducted in Tanzania (data collection from 1997 to 2002), Bangladesh (1999 to 2007), and India (2006 to 2010). One analysis was obtained from India\'s national program (2005 to 2009).

Schellenberg [@b4] was carried out in four rural districts of Tanzania, with two intervention clusters and two control clusters that were geographically contiguous and matched for mortality rates. Arifeen [@b1] was conducted in Bangladesh, in areas of a subdistrict where the sampling frame consisted of first-level outpatient facilities. Bhandari [@b2] was carried out in primary care health centres within a single district of a state in Haryana, India. In a second study from India, Mohan [@b3] collected data from 12 districts of India that had initiated IMCI and compared them with data from matched control districts.

#### Strategies

Interventions are summarized as an input matrix ([Table 3](#tbl3){ref-type="table"}) related to human resource policies, health systems strengthening, and strategies for community engagement. Trials varied substantially in range of inputs provided. The earliest trial comprised two IMCI components: training for basic health care workers, and drug supply combined with tools and manuals (Schellenberg [@b4]).

Arifeen [@b1] included training of basic health care workers but provided more substantive supervision, health service strengthening, and strategies for community engagement. Investigators added a new cadre of health worker halfway into the study for treatment of community pneumonia and diarrhoea.

Bhandari [@b2] included training of all cadres of health care workers consisting of human resource management strategies, drug supply, and community engagement, including support to village doctors, women\'s groups, and women\'s leaders.

Mohan [@b3] reported fewer inputs than Bhandari [@b2] but included home visits and drug supply.

The two trials in India (Bhandari [@b2]; Mohan [@b3]) modified the IMCI package to include a series of interventions specifically targeted at the neonate. These interventions were defined in the IMNCI guidelines by the Government of India (WHO [@b81]; WHO [@b85]).

Details of the interventions are included in [Table 4](#tbl4){ref-type="table"}. Routine health care was used for comparison in all trials.

#### Study design

Two studies were cluster-randomised trials (Arifeen [@b1]; Bhandari [@b2]); two were controlled before-after studies (Mohan [@b3]; Schellenberg [@b4]). Both cluster RCTs used appropriate methods to take clustering into account when reporting measures of treatment effect.

#### Outcomes

Arifeen [@b1] reported mortality in children younger than five years of age, while excluding death in the first week of life. Schellenberg [@b4] reported under-five mortality rates at baseline and at two years after implementation of IMCI. Bhandari [@b2] reported neonatal mortality, neonatal mortality beyond the first 24 hours of birth, and infant mortality.

In Arifeen [@b1], in the abstract of the article but not in the main text, study authors reported on the percentage difference in mortality rates in the last two years of the study (27.0/1000 in the IMCI group, 31.2/1000 in the control group). This is [not]{.ul} corrected for baseline (which is lower in the IMCI group), thus this estimate is inflated. We calculated absolute differences in death between the two groups in [Table 1](#tbl1){ref-type="table"}, as these data are more informative.

For [nutritional status]{.ul}, three studies reported wasting and stunting (Arifeen [@b1]; Bhandari [@b2]; Schellenberg [@b4]).

For [quality of care]{.ul}, Arifeen [@b1] reported on health facility readiness and quality of assessment and treatment of sick children.

For coverage of key IMCI deliverables, studies included the following.

All studies reported on measles immunization coverage.Studies reporting appropriate care seeking used different approachesAll studies reported on exclusive breast feeding but at different time points: four weeks (Bhandari [@b2]); four months (Schellenberg [@b4]); and six months (Arifeen [@b1]; Mohan [@b3]). Other outcomes are listed in the Characteristics of included studies table.

No study reported [satisfaction of mothers and service users.]{.ul}

#### Funding

Arifeen [@b1] and Schellenberg [@b4] were included in the Multi-Country Evaluation of IMCI Effectiveness, Cost, and Impact (MCE), which was co-ordinated by the Department of Child and Adolescent Health and Development of WHO. The World Health Organization funded Bhandari [@b2]. No source of funding was given for Mohan [@b3], but three study authors were (at the time of publication) affiliated with WHO or UNICEF.

### Excluded studies

The Characteristics of excluded studies table summarizes the reasons why studies were excluded. Of the 45 studies (53 reported papers):

we excluded three, as they had just one intervention and control cluster (Atakuoma [@b9]; Esaghi [@b19]; Rowe [@b43]);we excluded five, as the outcome was not of interest (Adam [@b5]; Gilroy [@b22]; Kelley [@b30]; Mahalli [@b33]; Prado [@b41]);we excluded 14, as a component of the IMCI was implemented but not the complete generic WHO IMCI (Ali [@b6], Ebuehi [@b15]; Ebuehi [@b16]; Ertem [@b18]; Gebresellasie [@b20]; Ghimire [@b21]; Hamad [@b24]; Harkins [@b25]; Igarashi [@b28]; Jin [@b29]; Pelto [@b40]; Santos [@b44]; Talsania [@b46]; Zaman [@b50]);we excluded 16, as they did not include a control group (Camara [@b11]; Chopra [@b12]; Chowdhury [@b13]; Core [@b14]; Edward [@b17]; Huicho [@b26]; Huicho [@b27]; Kumar [@b31]; Mohan [@b34]; Pariyo [@b39]; Rakha [@b42]; Senn [@b45]; Thompson [@b47]; Uzochukwu [@b48]; Wammanda [@b49]; Zhang [@b51]). In addition, the control group had partial rollout of the IMCI program in one trial (Moti [@b35]); andwe excluded one of the remaining studies as it was a cross-sectional survey with no baseline data and therefore did not qualify as a CBA trial (Naimoli [@b36]). Three publications were narrative reviews pertaining to IMCI that presented no data (Almagambetova [@b7]; Lulseged [@b32]; Oluwole [@b37]), and one was a secondary analysis of data (Gouws [@b23]). One trial assessed improvements to IMCI with addition of special \"supports\" (Osterholt [@b38]). Two trials did not pertain to IMCI and were obviously irrelevant (Bradley [@b10]; Zurovac [@b52]).

Risk of bias in included studies
--------------------------------

See [2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"} for summaries of risk of bias, and the Characteristics of included studies table for details of risk of bias and methods used in each trial. Arifeen changed the intervention when care seeking and referral completion did not turn out as expected. This impacted the indirectness and generalisability of the trial.

![Risk of bias graph: review authors\' judgements about each risk of bias item presented as percentages across all included studies.](CD010123-0001-f02){#fig2}

![Risk of bias summary: review authors\' judgements about each risk of bias item for each included study.](CD010123-0001-f03){#fig3}

Effects of interventions
------------------------

See: **Summary of findings for the main comparison** Integrated management of childhood illness strategy compared with routine care

### Mortality

Three studies summarized in [Table 5](#tbl5){ref-type="table"} reported effects of IMCI on mortality.

#### Child mortality

One trial and one CBA evaluated this. The Bangladesh trial estimated that child mortality may be 13% lower in the IMCI group, but the confidence intervals include no effect (RR 0.87, 95% CI 0.68 to 1.10, 5090 participants, *low-certainty evidence*). The Tanzania CBA study produced very similar estimates (RR 0.87, 95% CI 0.72 to 1.05). ([Analysis 1.1](#fig101){ref-type="fig"}).

In the Bangladesh trial, it is important to note that mortality in both intervention and control groups fell markedly over the six-year period. When the first two years were compared with the last two years, the rate fell from 70.0 to 49.3/1000 live births in the IMCI group, and from 65.6 to 50.5/1000 live births in the control group, but investigators detected no differences between intervention and control groups. Study authors reported that IMCI group mortality was slightly lower by 3.3% (95% CI -3.4 to 10.0, adjusted for baseline imbalance), but the estimate includes a null effect (Arifeen [@b1]).

#### Infant and neonatal mortality

Bhandari [@b2], who included a neonatal component to IMCI, reported data on these outcomes, adjusted for potential confounders ([Table 5](#tbl5){ref-type="table"}). The infant mortality hazard ratio (HR) suggests that infant mortality may be lower in the IMNCI group than in the control group (cluster-adjusted HR 0.85, 95% CI 0.77 to 0.94; low certainty of evidence; [Analysis 1.1](#fig101){ref-type="fig"}), although neonatal effects were marginal and confidence intervals included no effect (cluster-adjusted HR 0.91, 95% CI 0.80 to 1.03; [Analysis 1.1](#fig101){ref-type="fig"}). In a subgroup analysis, the neonatal mortality rate was lower in IMCI clusters in the subgroup delivered at home (cluster-adjusted HR 0.80,95% CI 0.68 to 0.93) but not in those delivered at a health facility (cluster-adjusted HR 1.06, 95% CI 0.91 to 1.23). This subgroup effect was preserved for infant mortality (home deliveries, cluster-adjusted HR 0.77, 95% CI 0.69 to 0.87; facility-based deliveries, cluster-adjusted HR 0.98, 95% CI 0.87 to 1.10). Study authors attributed the difference in mortality to more effective change in newborn care practices (including early breast feeding, exclusive breast feeding, delayed bathing, appropriate cord care) among home born babies compared with those delivered at the facility. The intervention may have improved timely seeking of health care for sick newborns, thereby affecting neonatal and infant mortality.

In a subsidiary analysis, we examined mortality among participants younger than five years of age, conducting a meta-analysis that combined child mortality with infant mortality. This post hoc analysis was justified on the basis that infant mortality accounts for 70% of under-five mortality ([Analysis 1.2](#fig102){ref-type="fig"}). Overall, under-five mortality may be reduced by IMCI (RR 0.85, 95% CI 0.78 to 0.93; two trials; 65,570 participants).

### Nutritional status

Three studies assessed nutritional status; we have summarized their findings in [Table 6](#tbl6){ref-type="table"} (Arifeen [@b1]; Bhandari [@b2]; Schellenberg [@b4]). Published data from Arifeen [@b1] were not cluster-adjusted, so we used an ICC of 0.01 in the meta-analysis (see Methods).

For stunting, all confidence intervals overlap, and we considered it not unreasonable to pool study results for the trials. Overall, we noted that there may be little or no effect on stunting (RR 0.94, 95% CI 0.84 to 1.06; two trials; *low-certainty evidence*; [Analysis 1.3](#fig103){ref-type="fig"}).

For wasting, we used the same estimate for the ICC. Analysis shows there is probably little or no effect of IMCI on wasting (RR 1.04, 95% CI 0.87 to 1.25; two trials; *moderate-certainty evidence*; [Analysis 1.4](#fig104){ref-type="fig"}).

The Tanzania CBA study gave similar estimates for both parameters.

### Quality of care

Arifeen [@b1] conducted extensive assessments of quality of care in facilities, but Schellenberg [@b4] measured fewer parameters ([Table 7](#tbl7){ref-type="table"}). Again, these data were collected by direct observation.

Prescribing at health facilities was measured in two studies. Performance in IMCI groups appeared considerably improved in the Bangladesh trial, and a small improvement in pneumonia correctly treated was found in Schellenberg [@b4], although the base performance level was low. Schellenberg [@b4] also measured administration of antimalarials for fever and found little or no difference following IMCI implementation ([Table 7](#tbl7){ref-type="table"}). As certainty of the evidence was very low, we do not know whether IMCI has a consistent effect on prescribing at health facilities.

Three studies measured prescribing by lay health care workers ([Table 8](#tbl8){ref-type="table"}). Investigators examined appropriate treatment under direct observation for three common illnesses: diarrhoea (and oral rehydration salts (ORS) use), pneumonia (antibiotic use), and fever (malaria treatment). As certainty of the evidence was very low, we do not know whether IMCI had a consistent effect on prescribing by lay health care workers.

Arifeen [@b1] examined the appropriateness of referrals (percentage of children coming to a facility who required referral and were actually referred) and found little or no difference between IMCI and non-IMCI clusters ([Table 7](#tbl7){ref-type="table"}).

Overall we found no consistent effect of the intervention on quality of care provided to beneficiaries.

### Coverage of IMCI deliverables

#### Vaccine coverage

All four studies evaluated immunization coverage among children in the study populations (Arifeen [@b1]; Bhandari [@b2]; Mohan [@b3]; Schellenberg [@b4]). Among these, three studied coverage of the measles vaccine and found probably little or no effect on measles vaccine coverage (RR 0.92, 95% CI 0.80 to 1.05; two trials; Tanzania CBA showed a similar result; [Analysis 1.5](#fig105){ref-type="fig"}).

Two studies evaluated coverage of the third dose of diphtheria, pertussis, and tetanus vaccine - one with very low coverage at follow-up (15.6% in the control group, 21.2% in the IMCI group; Bhandari [@b2]) and one with much higher coverage at follow-up (81.9% IMCI; 93% control; Schellenberg [@b4]; [Analysis 1.6](#fig106){ref-type="fig"}). The pattern was the same as for measles vaccine, with little or no evidence of improved coverage with IMCI.

#### Vitamin A coverage

Two studies reported vitamin A supplementation coverage. In the Bangladesh trial (Arifeen [@b1]), coverage was high in both intervention and control areas at baseline and at follow-up. In the Tanzania study, vitamin A coverage was low at baseline in both groups and was high at follow-up in both groups ([Table 9](#tbl9){ref-type="table"}). Analysis of end values shows that there was probably slightly better coverage in the control group of the Bangladesh trial ([Analysis 1.7](#fig107){ref-type="fig"}). Overall, there is probably little or no effect of IMCI on vitamin A coverage.

#### Appropriate care seeking

Care seeking was studied through various parameters in all four included studies with mixed results: Arifeen [@b1] suggested improvement in the IMCI group, as did Bhandari [@b2] (Table 10; [Analysis 1.9](#fig109){ref-type="fig"}). Schellenberg [@b4] did not demonstrate improvement. Mohan [@b3] reported on this and suggested better care seeking for ARI.

Mohan [@b3] also reported end values for \"change in percentage of institutional deliveries,\" with 9.2% for IMCI and 5.0% for control and no differences in change detected (RR 4.2%, 95% CI -3.8 to 12.2).

#### Exclusive breast feeding

Exclusive breast feeding was reported in four studies (Table 11), which showed mixed results of very low certainty ([Analysis 1.8](#fig108){ref-type="fig"}): One study (Bhandari [@b2]), which included home visits to encourage breast feeding, found a large effect. Other measures related to breast feeding in this study followed this pattern; in the intervention group, fewer pre-lacteal feeds were given and breast feeding was commenced within an hour of birth more commonly, although these measures were self reported. We noted little difference in relation to complementary feeding. The other three studies demonstrated no differences in breast feeding-related parameters.

#### Newborn care practices

Bhandari [@b2] examined several newborn care practices following implementation of IMCI. These practices included delayed bathing, cord care, and appropriate temperature maintenance. Investigators found improvement in all practices, except use of appropriate clothing to maintain newborn temperature while preventing hypothermia.

Discussion
==========

Summary of main results
-----------------------

See Summary of findings for the main comparison.

The integrated management of childhood illness (IMCI) strategies evaluated in these four studies included training of health care staff and management strengthening of health systems (all four studies), as well as home visiting (two studies). Two studies from India included care packages targeting the neonatal period.

Two studies (Tanzania and Bangladesh) showed that child mortality may be lower with IMCI, possibly as much as 28-32% lower, but the confidence interval also included no effect.

One study in India, which implemented the integrated management of neonatal and childhood illness (IMNCI) strategy, including post-natal home visits, examined infant and neonatal mortality, suggesting that neonatal and infant mortality may be lower in the IMNCI group than in the control group.

Three studies (Tanzania, India, Bangladesh) evaluated nutritional status and noted little or no effect on both stunting and wasting.

Investigators measured quality of care by observing prescribing for common illnesses in two studies (Tanzania and Bangladesh). Effects were mixed and ranged from no effect to quite large effects, so we do not know whether the effect on prescribing quality was consistent.

For coverage of IMCI deliverables, we examined vaccine coverage, appropriate care seeking, and exclusive breast feeding. Three studies (Tanzania, India, Bangladesh) estimated vaccine coverage for measles, reporting probably little or no effect on measles vaccine coverage; two of these studies measured the third dose of diphtheria, pertussis, and tetanus vaccine; and two measured vitamin A coverage, all providing little or no evidence of increased coverage with IMCI.

Four studies (two from India and one each from Tanzania and Bangladesh) reported appropriate care seeking, using information derived from careful questioning of mothers about recent illness. IMCI areas may show better reported care seeking behavior in some studies, but not in others.

All four studies recorded maternal responses on exclusive breast feeding. Results were mixed and were of very low certainty, with some studies indicating that exclusive breast feeding was higher in IMCI areas but was not very different in others.

No study reported satisfaction of mothers and service users.

Overall completeness and applicability of evidence
--------------------------------------------------

All included studies involved study populations from low- to middle-income countries (LMICs) with high infant and child mortality rates; these settings are expected to benefit from IMCI interventions. Three of the four studies evaluated the impact of all three components of IMCI, and the fourth did not include the community component. Thus all four studies did include the two important components, namely, training of workers and strengthening of health care systems, but most also included the community component. The nature of interventions under each heading varied among trials (see [Table 3](#tbl3){ref-type="table"}).

All included studies were substantive in scope and in length of follow-up. Control groups in all trials were comparable with intervention groups at baseline and continued to receive routine health care services as per ongoing programs. Thus any observed effects in the intervention groups are more likely to be attributable to the IMCI strategy than to spontaneous improvements noted over time. Evidence from these trials is largely applicable to real-life situations among populations in LMICs.

Three (out of four) studies were conducted in South Asia - two of these in India; thus the evidence base from African settings is particularly sparse.

Control groups in all studies received health care, so these studies evaluated the added value of IMCI or IMNCI. Such added value is likely to show a modest effect.

Quality of the evidence
-----------------------

Integrated management of childhood illness is a complex intervention, and conducting field trials to assess its impact is undoubtedly a challenging task. Therefore, generated evidence is valuable even if it is graded by the GRADE (Grades of Recommendation, Assessment, Development and Evaluation Working Group) approach as having low to moderate certainty ([Table 1](#tbl1){ref-type="table"}). Of the four studies included in this review, two were carefully conducted cluster-randomised controlled trials (Arifeen [@b1]; Bhandari [@b2]) with low risk of selection and recruitment bias, no attrition (loss of clusters), and good baseline comparability. The two controlled before-after studies (Mohan [@b3]; Schellenberg [@b4]) were cluster studies with purposive selection of control and intervention clusters.

All studies included in this systematic review had been funded or supported by the World Health Organization (WHO) or had serving employees of WHO as co-authors. As the World Health Organization is the primary institution responsible for facilitating global advocacy and implementation of IMCI, we were concerned about competing interests resulting in over-optimistic interpretation of study results. However, included studies were generally well conducted and reported.

Potential biases in the review process
--------------------------------------

Two of the studies were conducted in India, and the lead and senior authors are familiar with these research studies in their own country. However, the authorship team was aware of this potential bias and ensured that application of inclusion criteria, data extraction, and interpretation were neutral. During the process of peer review, we became aware of another trial (Boone [@b53]) that might be eligible for inclusion in the review and will be included when we update this review. It is unlikely that we missed any trials because such trials are likely to be large, to require extensive funding, and to be of interest to the World Health Organization, which promotes this strategy. Therefore they are likely to have been picked up by our exhaustive search strategy, which included contacting all relevant stakeholders to identify eligible trials.

Agreements and disagreements with other studies or reviews
----------------------------------------------------------

To our knowledge, no published systematic review has assessed the impact of IMCI implementation in population settings (in children younger than five) on mortality and other outcomes.

A recently published systematic review (Willey [@b87]) assessed the effectiveness of interventions to strengthen national health service delivery; the findings are consistent with our review.

Another systematic review (Nguyen [@b73]) assessed the impact of IMCI on the skills of health care workers. This review included cluster-randomised controlled trials (RCTs), pre/post studies, and cross-sectional studies and found that IMCI-trained workers performed better in classifying illnesses, prescribing medications, vaccinating children, counselling families, and administering oral therapies. We did not consider these outcomes in our review.

We identified two trials (Amorim [@b8]; Rowe [@b43]) that were excluded because they were non-randomised controlled trials with single comparison units. Notes of these findings are appended in the Characteristics of excluded studies table).

Authors\' conclusions
=====================

Implications for practice
-------------------------

Providing accessible comprehensive primary health care services to children in low- and middle-income countries seems a good approach to providing health care. This review indicates that IMCI may have a modest effect on mortality and may well be worth implementing, but policymakers need to be careful about justifying the considerable investment on the basis that it will result in large improvements in mortality.

One study measured neonatal and infant mortality and showed that these may be lower in the IMNCI group than in the control group. In this study, the strategy included neonatal care, emphasizing that these services have the potential to create impact during this period when mortality is high. IMCI programmes should consider including services directed at the neonate (\"IMCNI\") as an integral component of the strategy.

In addition, this strategy, variously implemented in these studies, did not show consistent effects on quality of care, and the certainty of evidence was very low because of concerns regarding precision, consistency, and directness. Therefore we do not know whether IMCI improves quality of care.

There is a continuing need to assure the components of the IMCI package are delivered appropriately, that coverage is maintained and that managerial and support approaches are taken to assure that appropriate, good quality care is in place.

Implications for research
-------------------------

Demonstrating an effect on mortality of effective implementation of routine primary neonatal and child health care services is a large and expensive undertaking. Many influences on child mortality occur over time, and studies must be large. Efforts by researchers to evaluate effects of IMCI help to demonstrate this. In the meantime, services and health may be improving over time, as was clear in Arifeen [@b1], which reported dramatic falls in child mortality over the five years of the study in both intervention and control arms.

Important further research will involve evaluating strategies that improve access to, and the quality of, various components of delivery of a comprehensive package of primary child health care, with the IMCI package serving as a base for countries to draw on and modify as appropriate.

The review author team was supported by a grant from the Effective Health Care Research Consortium. This Consortium is funded by aid provided by the UK Government for the benefit of developing countries (Grant: 5242). The views expressed in this publication do not necessarily reflect UK government policy. Finalization of this review was carried out as part of the World Health Organization (WHO)/Cochrane Collaboration/Micronutrient Initiative/Cornell University Summer Institute for Systematic Reviews in Nutrition for Global Policy Making, hosted at the Division of Nutritional Sciences, Cornell University, Ithaca, New York, USA, 7 to 18 July 2014. The World Health Organization supported this program through the School of Continuing Education and Summer Programs in 2014.

Characteristics of studies
==========================

Characteristics of included studies \[ordered by study ID\]
-----------------------------------------------------------

###### 

Arifeen 2009

  ------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Methods                                                                  **Design:** cluster-randomised controlled trial\                                                                                                                                                                                                                                                                                                                     
                                                                           **Unit of randomisation:** first-level government health facilities                                                                                                                                                                                                                                                                                                  

  Participants                                                             Children in the health facility catchment area\                                                                                                                                                                                                                                                                                                                      
                                                                           Bangladesh in one subdistrict not covered by ICCDR,B health care services\                                                                                                                                                                                                                                                                                           
                                                                           Inclusion criteria: 20 of 24 first-level outpatient facilities in the study area, along with their catchment areas. We excluded four units because substantial portions of their catchment populations received child health care services from ICDDR,B, not from government facilities\                                                                             
                                                                           Mean numbers of children \< 5 years of age in final census 2006-2007: 2045 (intervention); 3045 (control)                                                                                                                                                                                                                                                            

  Interventions                                                            **IMCI training**\                                                                                                                                                                                                                                                                                                                                                   
                                                                           **Systems interventions:**\                                                                                                                                                                                                                                                                                                                                          
                                                                           community health interventions                                                                                                                                                                                                                                                                                                                                       

  Outcomes                                                                 **Mortality** Mortality in those younger than 5 years of age (7th day to 5 years) **Healthy practices by care giver** Exclusive breast feeding until 6 months of ageComplementary feedingCare seeking **Quality of care** Quality of careCoverage of IMCI deliverables **Nutritional status** WastingStunting Mortality estimates obtained from population surveys   

  Notes                                                                    **Objective:** to assess effects (and cost-effectiveness) of IMCI on mortality and nutritional status in children \< 5 years of age\                                                                                                                                                                                                                                 
                                                                           **Location:** Bangladesh, in Matlab upazilla (subdistrict), not covered by child and reproductive health services provided by the ICDDR,B: Centre for Health and Population Research Total study population was about 350,000                                                                                                                                        

  *Risk of bias*                                                                                                                                                                                                                                                                                                                                                                                                                                

  Bias                                                                     Authors\' judgement                                                                                                                                                                                                                                                                                                                                                  Support for judgement

  Random sequence generation (selection bias)                              Low risk                                                                                                                                                                                                                                                                                                                                                             Random allocation of 20 facility/catchment area units between pairs matched for facility type, geographical distribution, baseline mortality levels, and catchment population size\
                                                                                                                                                                                                                                                                                                                                                                                                                                                Allocated by blindly drawing a card with unit names from each pair and assigning it to IMCI, then assigning the other to comparison

  Allocation concealment (selection bias)                                  Low risk                                                                                                                                                                                                                                                                                                                                                             \"concealed until groups assigned\"

  Recruitment bias                                                         Low risk                                                                                                                                                                                                                                                                                                                                                             Units in each pair were randomly selected (see above)

  Blinding of participants and personnel (performance bias) All outcomes   Unclear risk                                                                                                                                                                                                                                                                                                                                                         Not mentioned

  Blinding of outcome assessment (detection bias) All outcomes             Unclear risk                                                                                                                                                                                                                                                                                                                                                         Not mentioned

  Incomplete outcome data (attrition bias) All outcomes                    Low risk                                                                                                                                                                                                                                                                                                                                                             No loss of clusters

  Selective reporting (reporting bias)                                     Low risk                                                                                                                                                                                                                                                                                                                                                             No evidence of selective reporting

  Other bias                                                               High risk                                                                                                                                                                                                                                                                                                                                                            Study teams monitored coverage throughout the study. Early findings for care seeking and referral completion suggest that coverage was not increasing as rapidly as expected, leading to changes in the intervention

  Baseline imbalance                                                       Low risk                                                                                                                                                                                                                                                                                                                                                             IMCI and comparison areas were similar at baseline

  Were baseline outcome measurements similar                               Low risk                                                                                                                                                                                                                                                                                                                                                             Yes

  Loss of clusters                                                         Low risk                                                                                                                                                                                                                                                                                                                                                             No loss of clusters reported

  Incorrect analysis                                                       Low risk                                                                                                                                                                                                                                                                                                                                                             Done correctly. Adjusted at catchment/facility level for clustering, using STATA

  Study adequately protected against contamination                         Low risk                                                                                                                                                                                                                                                                                                                                                             The same children were monitored for health-related outcomes as at the first visit for data collection
  ------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Bhandari 2012

  ------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Methods                                                                  **Design:** cluster-randomised controlled trial\                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                           **Unit of randomisation:** health centre                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Participants                                                             Children in the catchment area of health centres included\                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                           Inclusion criteria: 18 clusters selected in the state of Haryana for the purpose of this study\                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                           Exclusion criteria: none stated                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Interventions                                                            Training health care workers to implement integrated management of neonatal and childhood illnessProviding systems intervention to improve care deliveryImproving community health practices                                                                                                                                                                                                                                                                                                          

  Outcomes                                                                 **Mortality** Infant mortalityNeonatal mortalityPost-neonatal mortality **Standard health practices** Newborn care practices Care seeking behavior Immunization coverage Wasting and stunting Complementary feeding                                                                                                                                                                                                                                                                                   

  Notes                                                                    **Objective:** to assess India\'s adapted IMCI policy (which included home visits for early newborn care) on newborn and infant mortality, and on newborn care practices\                                                                                                                                                                                                                                                                                                                             
                                                                           **Location:** communities with 1.1 million population served by 18 primary health centres in the district of Faridabad, Haryana, India. The population of each primary health centre ranged from 10,694 to 72,059. About half the mothers had never been to school, and two-thirds of births took place at home. Previous studies in the same area showed that 35% of newborns were of low birth weight and 60% of sick children were taken for care to medically unqualified private practitioners   

  *Risk of bias*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Bias                                                                     Authors\' judgement                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Support for judgement

  Random sequence generation (selection bias)                              Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \"\...divided the clusters into three strata containing six clusters each based on neonatal mortality rate. An independent epidemiologist generated 10 stratified randomisation schemes to allocate the clusters to intervention or control groups. The authors examined all 10 potential randomisation schemes, and excluded three because of chance large differences between the groups. The authors then randomly selected one of the remaining seven allocation schemes by a computer generated random number\"

  Allocation concealment (selection bias)                                  High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Not mentioned, study author clarification sought

  Recruitment bias                                                         Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              No obvious recruitment bias (see above)

  Blinding of participants and personnel (performance bias) All outcomes   Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Blinding of community not clear. Surveillance team was not told the intervention status of the community they were visiting

  Blinding of outcome assessment (detection bias) All outcomes             High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Not done

  Incomplete outcome data (attrition bias) All outcomes                    Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Low attrition for neonatal mortality - the primary outcome. During outcome assessment period (January 2008 to March 2010), study authors registered a total of 77,587 pregnancies, for which outcomes were not known in 10,239 (13.2%). Of these, 9954 women were still pregnant when recruitment of live births in the trial was stopped; few pregnant women (285) had left the area or died. Study authors recorded 5147 (6.6%) miscarriages/abortions, 1499 (1.9%) stillbirths, and 60,702 (78.2%) live births in the study area. According to plan, follow-up ended 6 weeks after recruitment was completed. Consequently, although almost all recruited live born infants were followed for the newborn period (97.8%), only 75.4% were followed for 6 months and 52.6% until the end of infancy

  Selective reporting (reporting bias)                                     Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              All primary outcomes reported. Perinatal mortality (stillbirths and deaths between birth and day 7 of life) 16 and post-neonatal mortality were added to reported outcomes for completeness

  Other bias                                                               Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              None detected

  Baseline imbalance                                                       Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Not apparent

  Were baseline outcome measurements similar                               Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Yes, all similar (except on average, IMCI centres slightly farther from main road)

  Loss of clusters                                                         Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              No loss of clusters reported

  Incorrect analysis                                                       Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Correct for cluster design, using shared frailty option to account for cluster randomisation (except for neonatal deaths beyond first 24 hours of birth and post-neonatal deaths, for which investigators adjusted for cluster design with robust standard errors, as the shared frailty option failed)

  Study adequately protected against contamination                         Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Although contiguous, the 18 clusters are large, and the way health care and worker responsibilities are organized within a primary health centre area makes risk of contamination low
  ------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Mohan 2011

  ------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Methods                                                                  **Design:** controlled before-after study. Design was retrospective based on implementation\                                                                                                                                                                                                                                  
                                                                           **Unit of study:** district                                                                                                                                                                                                                                                                                                   

  Participants                                                             Children in districts evaluated\                                                                                                                                                                                                                                                                                              
                                                                           **Inclusion criteria:** The 12 districts (of India) that had initiated IMNCI in 2005 were selected (subsequently referred to as \"early\" IMNCI districts). For each \"early\" IMNCI district, a control district from the same state, matched on IMR and proportion of scheduled caste or scheduled tribe, was identified\   
                                                                           **Exclusion criteria:** none stated                                                                                                                                                                                                                                                                                           

  Interventions                                                            Training health care workers to implement IMNCI Providing systems intervention to improve care delivery Improving community health practices                                                                                                                                                                                  

  Outcomes                                                                 **Home practices** Early initiation of breast feeding Exclusive breast feeding until 6 months ORS-use rates **Service use and coverage** Percentage of deliveries conducted at a health facility (institutional delivery) Full immunization Percentage of children with ARI who sought care                                   

  Notes                                                                                                                                                                                                                                                                                                                                                                                                  

  *Risk of bias*                                                                                                                                                                                                                                                                                                                                                                                         

  Bias                                                                     Authors\' judgement                                                                                                                                                                                                                                                                                                           Support for judgement

  Random sequence generation (selection bias)                              High risk                                                                                                                                                                                                                                                                                                                     Non-randomised trial

  Allocation concealment (selection bias)                                  High risk                                                                                                                                                                                                                                                                                                                     Retrospective data analyses with no mention in text of allocation concealment

  Recruitment bias                                                         High risk                                                                                                                                                                                                                                                                                                                     No mention has been made of criteria for selection of intervention clusters

  Blinding of participants and personnel (performance bias) All outcomes   Unclear risk                                                                                                                                                                                                                                                                                                                  Observational study using district-level household survey: blinding not relevant

  Blinding of outcome assessment (detection bias) All outcomes             High risk                                                                                                                                                                                                                                                                                                                     Not mentioned but unlikely to have been done based on study design

  Incomplete outcome data (attrition bias) All outcomes                    Low risk                                                                                                                                                                                                                                                                                                                      No loss of clusters, as this is a retrospective analysis

  Selective reporting (reporting bias)                                     Low risk                                                                                                                                                                                                                                                                                                                      All coverage indicators mentioned in methods section (Table 1) have been reported

  Other bias                                                               High risk                                                                                                                                                                                                                                                                                                                     Data from independent surveys incidentally conducted before and after intervention used for coverage indicators. May not be exactly before-after data

  Baseline imbalance                                                       Low risk                                                                                                                                                                                                                                                                                                                      For each \"early\" IMNCI district, a control district from the same state, matched on IMR and proportion of scheduled caste or scheduled tribe, was identified

  Were baseline outcome measurements similar                               Unclear risk                                                                                                                                                                                                                                                                                                                  Baseline outcome measurements not mentioned in published text

  Loss of clusters                                                         Low risk                                                                                                                                                                                                                                                                                                                      No loss of clusters mentioned in results/analysis, as the study analysed data on a retrospective basis

  Incorrect analysis                                                       Low risk                                                                                                                                                                                                                                                                                                                      Weighted averages of percentage change in coverage levels were calculated for intervention and control districts. Net difference in changes in coverage was then compared between intervention and control districts using linear regression with adjustment for clustering and for sampling weights

  Study adequately protected against contamination                         Unclear risk                                                                                                                                                                                                                                                                                                                  Not mentioned
  ------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Schellenberg 2004

  ------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Methods                                                                  **Design:** controlled before-after comparison (also called a \"non-randomised controlled clinical trial\"), with monitoring of process measures to improve internal validity and to determine whether changes are the result of intervention or other factors\                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                           **Unit of allocation:** district                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Participants                                                             Children in study districts\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                           Inclusion criteria The 2 IMCI districts - Morogoro Rural and Rufiji - started to implement IMCI in 1997--1998, and the 2 comparison districts - Kilombero and Ulanga - started implementation in 2002 The 2 comparison districts were chosen for several reasons: They were geographically contiguous although separated from intervention districts by an uninhabited game reserve, so population movement between intervention and comparison areas was negligible; investigators reported continuing demographic surveillance; had similar or lower mortality rates; and had no immediate plans to implement IMCI 1932 children \< 5 years of age in final survey   

  Interventions                                                            IMCI training given Systems intervention provided                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Outcomes                                                                 **Mortality** Child mortality\* **Standard health practices** Exclusive breast feeding\* Care seeking for children with danger signs\* **Quality of care** ORS prescription for diarrhoea\* Antimalarials for fever\* Vaccine coverage\* **Nutritional** Wasting Stunting Underweight \*Specified primary outcomes                                                                                                                                                                                                                                                                                                                                                     

  Notes                                                                    **Objective:** to measure effects of IMCI on child health and survival\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                           **Location:** southern area of Tanzania, poor, rural area with a network of public health facilities                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  *Risk of bias*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Bias                                                                     Authors\' judgement                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Support for judgement

  Random sequence generation (selection bias)                              High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Not random

  Allocation concealment (selection bias)                                  High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              No allocation

  Recruitment bias                                                         High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Intervention sites chose to implement IMCI; control sites had \"no immediate plans\"

  Blinding of participants and personnel (performance bias) All outcomes   High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Not blinded

  Blinding of outcome assessment (detection bias) All outcomes             High risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Not blinded

  Incomplete outcome data (attrition bias) All outcomes                    Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               No loss of clusters/population

  Selective reporting (reporting bias)                                     Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Quality outcomes appear comprehensive

  Other bias                                                               Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               No other apparent source of bias

  Baseline imbalance                                                       Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Baseline data available from 1999, when IMCI had been partially rolled out in intervention areas

  Were baseline outcome measurements similar                               Unclear risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Baseline data available from 1999, when IMCI had been partially rolled out in intervention areas. Study authors also mention:\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \"We could not do a before-IMCI health facility survey because implementation of IMCI had already started before this study began in 1999\"

  Loss of clusters                                                         Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               No loss of clusters

  Incorrect analysis                                                       Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Adjustments for age (\< 1 year and 1 to 4 years) and rainfall (estimated from remote sensing data) were made with Poisson regression models, and\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  between-district differences were compared by *t*-test-based methods of adjusted residuals, as appropriate for clustered data, with a small number of clusters in only 4 districts. P values from this approach are likely to be conservative

  Study adequately protected against contamination                         Low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               The 2 comparison districts were chosen for several reasons: They were geographically contiguous although separated from intervention districts by an uninhabited game reserve, so population movement between intervention and comparison areas was negligible
  ------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ARI: acute respiratory infection

ICDDR,B: International Center for Diarrheal Disease Research, Bangladesh

IMCI: integrated management of childhood illness

IMNCI: integrated management of neonatal and childhood illness

ORS: oral rehydration salts

Characteristics of excluded studies \[ordered by study ID\]
-----------------------------------------------------------

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                    Reason for exclusion
  ------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Adam 2009                Involves secondary analysis from an included trial; outcome not of interest

  Ali 2005                 CBA study with 1 intervention and 1 control cluster (district)\
                           Intervention comprised a non-specific community-based public health intervention derived from community component of IMCI

  Almagambetova 2000       Short report summarizing conclusions from a strategy implementation conference on IMCI, not primary research

  Amorim 2008              Retrospective analysis in which allocation was done by level of performance of clusters in implementation of IMCI, which is likely to confound results as well Baseline data (before implementation of IMCI) not available ITT analysis not done \[The analysis, mentioned in the Discussion, showed 72% of 175 children were correctly managed in IMCI areas; 56% of 183 were correctly managed in non-IMCI facilities (P value = 0.02). IMCI was associated with 30% higher quality of case management\]

  Atakuoma Dzayisse 2006   Non-randomised controlled cross-sectional trial with 1 intervention and 1 control cluster

  Bradley 2005             Intervention did not involve IMCI

  Camara 2008              No control group

  Chopra 2005              No control group

  Chowdhury 2008           Observational study, no control group (subset of Arifeen study that studies the outcome of treatment guidelines for pneumonia in IMCI area)

  Core Group 2009          Study has no control group\
                           Studies the impact of community IMCI component only

  Ebuehi 2009              Studies the impact of community IMCI component only (3 components vs 2 components of IMCI). Only 2 study clusters: 1 in the intervention arm and the other in the control arm

  Ebuehi 2010              CBA study with only 1 intervention and 1 control cluster; intervention involved assessed only the C-IMNCI component of IMCI. Intervention zone had all 3 components vs first 2 components of IMCI in control area

  Edward 2007              Pre- and post-intervention study with **no control group**

  Ertem 2006               Intervention involved care for development, which is a component of IMCI, and not generic IMCI; outcome studied was mental development, which was not of interest

  Esaghi 2012              Non-randomised controlled trial with 1 study group and 1 control cluster. Excluded because fewer than 2 clusters in study and control groups

  Gebresellasie 2011       Intervention consisted of health education component only for IMCI. Essential component of health worker training was missing. Only 1 control and 1 intervention component in a non-randomised controlled trial

  Ghimire 2010             Intervention involved health education component only for IMCI. Essential component of health worker training was missing

  Gilroy 2004              Outcome not of interest; pertains to counselling tasks by IMCI provider

  Gouws 2004               Study is a secondary analysis of data collected from WHO MCE studies

  Hamad 2011               Intervention consisted only of health education component of IMCI. Essential component of health worker training was missing

  Harkins 2008             Assesses effects of community IMCI only; no control group

  Huicho 2005              No control group

  Huicho 2008              Observational study, no control group\
                           Outcomes not of interest

  Igarashi 2010            Intervention consisted of assessment of GMP+, which is a community-based program based on PHC and IMCI. IMCI services provided in both control and intervention areas

  Jin 2007                 Intervention involved care for development module, which is part of IMCI, and not the WHO generic IMCI\
                           Outcome studied was mental development, which was not of interest

  Kelley 2001              Intervention consisted of performance feedback on compliance with IMCI protocol by health care workers

  Kumar 2009               Study compared 5 days vs 8 days of training of health care workers on the basis of performance; no control group included

  Lulseged 2002            Narrative review of Ethiopia\'s experience with IMCI; no data presented

  Mahalli 2011             Retrospective cohort study with 1 study group and 1 control cluster\
                           Excluded because fewer than 2 clusters were included in study and control groups, and outcome was drug prescribing practices, which was not of interest

  Mohan 2004               Doctors in both intervention and control clusters received training of different duration; no control group

  Moti 2008                Comparison of 1 implementation cluster vs 1 control cluster Control cluster also had partial rollout of IMCI program

  Naimoli 2006             Study is a cross-sectional survey conducted in 2 control and 2 intervention clusters 6 to 12 months after implementation of IMCI, with no baseline data; does not qualify as a CBA trial

  Oluwole 2000             Editorial reviewing the impact of IMCI, not an original research study

  Osterholt 2009           Study compared provision of IMCI with \"usual\" supports vs IMCI training with special supports (job aids, non-financial incentives, and supervision of workers and Supervisors). Thus health care workers received IMCI training in both groups with no control group included

  Pariyo 2005              No study and intervention population. Analysis compares the performance of health care workers by IMCI training\
                           No data on performance of health care workers before they were trained for IMCI

  Pelto 2004               Intervention involved an IMCI derived nutrition counselling protocol, not the entire generic IMCI training

  Prado 2006               Intervention involved Family Health Program, in whose context IMCI is being implemented,\
                           but involved 1 control and intervention cluster only. Outcome of maternal knowledge, which was not of interest

  Rakha 2013               No control group (retrospective analysis of mortality data before and after implementation of IMCI)

  Rowe 2011                Non-randomised controlled trial with 1 intervention and 1 control cluster. Excluded because fewer than 2 clusters were found in study and control groups\
                           \[the analysis is mentioned in the Discussion. In intervention area, mortality decreased (risk ratio (RR) 0.870, 95% CI 0.841 to 0.900); in comparison area, mortality unchanged (RR 1.013, 95% CI 0.979 to 1.049). Intervention-area trend was 14.1% lower than comparison-area trend (95% CI 9.8% to 18.2%)

  Santos 2001              Intervention consisted of IMCI-derived nutrition counselling protocol, not the entire generic IMCI training

  Senn 2011                No control group

  Talsania 2011            Intervention consisted of health education component only for IMCI. Essential component of health care worker training was missing

  Thompson 2009            Study has no control group. Studies the impact of community IMCI component only

  Uzochukwu 2008           Assesses effects of short-term training of IMCI on health care worker performance with **no control group**

  Wammanda 2003            No control group; intervention does not involve IMCI training; outcome (cost of drugs prescribed) not of interest

  Zaman 2008               Study had just 1 module of IMCI, namely, nutrition counselling, not generic IMCI as the intervention

  Zhang 2007               Pre- and post-intervention field survey with **no control group**

  Zurovac 2006             Qualitative review of studies on treatment of febrile illness in sub-Saharan Africa -- obviously irrelevant
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CBA: controlled before-after study

CI: confidence interval

C-IMNCI: community integrated management of neonatal and childhood illness

IMCI: integrated management of childhood illness

ITT: intention-to-treat

MCE: Multi-Country Evaluation of IMCI Effectiveness, Cost and Impact

PHC: primary health care

RR: risk ratio

WHO: World Health Organization

Characteristics of studies awaiting assessment \[ordered by study ID\]
----------------------------------------------------------------------

###### 

Boone 2016

  --------------- --------------------------------------------------------------------------------------------------------------------------
  Methods         **Design:** cluster RCT\
                  **Unit of allocation:** villages or groups of villages

  Participants    Women between 15 and 49 years of age; those who were primary care givers of children younger than 5 years of age\
                  Children younger than 5 years of age

  Interventions   Providing IMCI training of community health care workers Improving community health practices

  Outcomes        Under 5 mortality Neonatal and infant mortality Child morbidity Maternal mortality Treatment practices for sick children

  Notes           
  --------------- --------------------------------------------------------------------------------------------------------------------------

· Characteristics of studies, Characteristics of studies awaiting classification: Insert these footnotes at end of section:

IMCI: integrated management of childhood illness

RCT: randomised controlled trial

Data and analyses
=================

###### 

IMCI versus standard services

  -------------------------------------------------------------------------- ---------------- --------------------- ----------------------------- ---------------------
  Outcome or subgroup title                                                  No. of studies   No. of participants   Statistical method            Effect size
  [1 Mortality](#fig101){ref-type="fig"}                                     3                                      Rate Ratio (Fixed, 95% CI)    Totals not selected
   [1.1 Neonatal mortality (RCT)](#fig101){ref-type="fig"}                   1                                      Rate Ratio (Fixed, 95% CI)    0.0 \[0.0, 0.0\]
   [1.2 Infant mortality (RCT)](#fig101){ref-type="fig"}                     1                                      Rate Ratio (Fixed, 95% CI)    0.0 \[0.0, 0.0\]
   [1.3 Child mortality (RCT)](#fig101){ref-type="fig"}                      1                                      Rate Ratio (Fixed, 95% CI)    0.0 \[0.0, 0.0\]
   [1.4 Child mortality (CBA)](#fig101){ref-type="fig"}                      1                                      Rate Ratio (Fixed, 95% CI)    0.0 \[0.0, 0.0\]
  [2 Mortality (infant and child combined)](#fig102){ref-type="fig"}         2                                      Rate Ratio (Fixed, 95% CI)    0.85 \[0.78, 0.93\]
   [2.1 Child mortality](#fig102){ref-type="fig"}                            1                                      Rate Ratio (Fixed, 95% CI)    0.87 \[0.68, 1.10\]
   [2.2 Infant mortality](#fig102){ref-type="fig"}                           1                                      Rate Ratio (Fixed, 95% CI)    0.85 \[0.77, 0.94\]
  [3 Stunting](#fig103){ref-type="fig"}                                      3                                      Risk Ratio (Random, 95% CI)   Subtotals only
   [3.1 Cluster RCTs](#fig103){ref-type="fig"}                               2                                      Risk Ratio (Random, 95% CI)   0.94 \[0.84, 1.06\]
   [3.2 CBA studies](#fig103){ref-type="fig"}                                1                                      Risk Ratio (Random, 95% CI)   1.06 \[0.92, 1.23\]
  [4 Wasting](#fig104){ref-type="fig"}                                       3                                      Risk Ratio (Fixed, 95% CI)    Subtotals only
   [4.1 Cluster RCTs](#fig104){ref-type="fig"}                               2                                      Risk Ratio (Fixed, 95% CI)    1.04 \[0.87, 1.25\]
   [4.2 CBA studies](#fig104){ref-type="fig"}                                1                                      Risk Ratio (Fixed, 95% CI)    1.20 \[0.54, 2.68\]
  [5 Measles vaccine coverage](#fig105){ref-type="fig"}                      3                                      Risk Ratio (Fixed, 95% CI)    Subtotals only
   [5.1 Cluster RCTs](#fig105){ref-type="fig"}                               2                                      Risk Ratio (Fixed, 95% CI)    0.92 \[0.80, 1.05\]
   [5.2 CBA studies](#fig105){ref-type="fig"}                                1                                      Risk Ratio (Fixed, 95% CI)    0.95 \[0.89, 1.01\]
  [6 DPT vaccine coverage](#fig106){ref-type="fig"}                          2                                      Risk Ratio (Fixed, 95% CI)    Subtotals only
   [6.1 Cluster RCTs](#fig106){ref-type="fig"}                               1                                      Risk Ratio (Fixed, 95% CI)    0.95 \[0.68, 1.33\]
   [6.2 CBA studies](#fig106){ref-type="fig"}                                1                                      Risk Ratio (Fixed, 95% CI)    0.86 \[0.80, 0.92\]
  [7 Vitamin A vaccine coverage](#fig107){ref-type="fig"}                    2                                      Risk Ratio (Fixed, 95% CI)    Subtotals only
   [7.1 Cluster RCTs](#fig107){ref-type="fig"}                               1                                      Risk Ratio (Fixed, 95% CI)    0.93 \[0.88, 0.98\]
   [7.2 CBA studies](#fig107){ref-type="fig"}                                1                                      Risk Ratio (Fixed, 95% CI)    1.00 \[0.90, 1.12\]
  [8 IMCI deliverable - exclusive breast feeding](#fig108){ref-type="fig"}   3                                      Risk Ratio (Fixed, 95% CI)    Totals not selected
   [8.1 Cluster RCTs](#fig108){ref-type="fig"}                               2                                      Risk Ratio (Fixed, 95% CI)    0.0 \[0.0, 0.0\]
   [8.2 CBA studies](#fig108){ref-type="fig"}                                1                                      Risk Ratio (Fixed, 95% CI)    0.0 \[0.0, 0.0\]
  [9 Appropriate care seeking](#fig109){ref-type="fig"}                      3                                      Risk Ratio (Fixed, 95% CI)    Totals not selected
  -------------------------------------------------------------------------- ---------------- --------------------- ----------------------------- ---------------------

![Comparison 1 IMCI versus standard services, Outcome 1 Mortality.](CD010123-0001-f04){#fig101}

![Comparison 1 IMCI versus standard services, Outcome 2 Mortality (infant and child combined).](CD010123-0001-f05){#fig102}

![Comparison 1 IMCI versus standard services, Outcome 3 Stunting.](CD010123-0001-f06){#fig103}

![Comparison 1 IMCI versus standard services, Outcome 4 Wasting.](Cd010123-0001-f07){#fig104}

![Comparison 1 IMCI versus standard services, Outcome 5 Measles vaccine coverage.](Cd010123-0001-f08){#fig105}

![Comparison 1 IMCI versus standard services, Outcome 6 DPT vaccine coverage.](CD010123-0001-f09){#fig106}

![Comparison 1 IMCI versus standard services, Outcome 7 Vitamin A vaccine coverage.](CD010123-0001-f10){#fig107}

![Comparison 1 IMCI versus standard services, Outcome 8 IMCI deliverable - exclusive breast feeding.](CD010123-0001-f11){#fig108}

![Comparison 1 IMCI versus standard services, Outcome 9 Appropriate care seeking.](CD010123-0001-f12){#fig109}

ADDITIONAL TABLES
=================

###### 

IMCI components

  ------------------------------------------------------------ ---------------------------------------- ------------------------------------------------- -------------------- ------- ------- -------
                                                                                                                                                          Schellenberg [@b4]   [@b1]   [@b3]   [@b2]
  **Human resources policies for health care professionals**   IMCI training                            Basic health care worker                          Y                    Y       Y       Y
                                                                                                        Senior/other                                                                   Y       Y
                                                                                                        Doctors                                                                                Y
                                                                                                        TBA                                                                                    Y
                                                                                                        Refresher                                                                              
                                                                                                        Private sector                                                                         Y
                                                               Staff recruitment                        Filling vacancies                                                                      Y
                                                                                                        New cadre of community health care worker (CHW)                        Y               
                                                               Conditions of service                    Cash incentives                                                                        Y
                                                               Management                               Home visits                                                            Y       Y       Y
                                                               Supervision and monitoring                                                                 Y                    Y       Y       
  **Health system strengthening**                              Tools and manuals including guidelines   Supply education materials                        Y                    Y               
                                                               Additional equipment and drugs           Drug supply                                       Y^a^                 Y       Y       Y
                                                               Supply minor equipment                                                                     Y                                    
  **Strategies for community engagement**                      Training                                 Unqualified village doctors                                            Y               Y
                                                               Social development                       Establishing mother/women group meetings                               Y               Y
                                                                                                        Support of community leaders/volunteers                                Y               
                                                                                                        Community theatre                                                      Y               
  ------------------------------------------------------------ ---------------------------------------- ------------------------------------------------- -------------------- ------- ------- -------

**IMCI:** integrated management of childhood illness; **TBA:** traditional birth attendant

^a^Assumed, as the study is an assessment of first 2 components of World Health Organization (WHO) generic integrated management of childhood illness (IMCI)

###### 

Details of inputs described narratively

  -------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Study**            **Input**
  Schellenberg [@b4]   Incorporated 2 components of integrated management of childhood illness (IMCI), namely, training of health care workers and health system strengthening. All health care workers at the primary level received 11 days of training. IMCI nutrition education and counselling cards for educating mothers were prepared after operational research and subsequently translated into Swahili language to improve community practices. Health systems were strengthened using IMCI processes and by providing financial resources of approximately \$0.92 per capita to implementing districts
  Arifeen [@b1]        Incorporated all 3 components of IMCI. Health care workers were trained using the 11-day course, followed by a 3-day course on breast feeding counselling. Health systems strengthening consisted of making additional drugs available in the intervention area, and setting up a facility-level drug tracking and reporting system. Job aids such as weighing scales, timer to count respiratory rate, thermometers, chart booklets, and locally adapted cards as aids for counselling mothers were provided to all intervention clusters. To improve community practices, special emphasis was given to messages related to pneumonia and malnutrition and to 3 practice areas, namely, care seeking for sick children, home management of illness, and responsive feeding
  Mohan [@b3]          Retrospectively collected data about IMCI implementation from 12 districts that started implementation in 2005. Details of the intervention have not been described specifically for these 12 districts but are available for the entire country as part of a standard guideline. Training consisted of the 8-day course for community-based workers and auxiliary nurse midwives and an additional 2 days for supervisors. Workers are supposed to receive basic drugs and supplies as per guidelines of the Reproductive and Child Health II and Integrated Child Development Scheme (ICDS) programs. Community health practices include home visits to all newborns during which health care workers ensure exclusive breast feeding, provide counsel on temperature maintenance, explain danger signs, assess newborns (and other sick children) and refer them to an appropriate health facility, if required
  Bhandari [@b2]       Health care workers were trained with the 8-day IMNCI Basic Health Worker Course, and specialists received the 11-day IMNCI Course for Physicians. Health systems interventions included (1) strengthened supervision of community health care workers and nurses and filling of vacant supervisor positions; (2) task-based incentives to include IMNCI activities; and (3) establishment of drug depots in villages to ensure regular supply of drugs. Community health care workers made scheduled post-natal home visits, promoted breast feeding, delayed bathing, provided cord care, and responded to care seeking for illness. They also ran women\'s health group meetings to increase awareness of healthy newborn care practices
  -------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Results: mortality

  ------------------------ ----------------------- ------------------ ------------------------------------- -------------------------------------- ---------------------------------------------- ---------------------------- ------------------------ ------------------------------------------
  **Outcome**              **Trial ID**            **Study design**   **Pre-intervention mortality rate**   **Post-intervention mortality rate**   **Cluster-adjusted relative effect(95% CI)**   **Coverage indicators**\                              
                                                                                                                                                                                                  **analysis summary**                                  

  **IMCI**                 **Control**             **IMCI**           **Control**                                                                                                                                                                       

  **Neonatal mortality**   Bhandari [@b2]^a^       Cluster RCT        32.6/1000 live births\                32.4/1000 live births\                 41.9/1000 live births\                         43/1000 live births\         **Hazard ratio 0.91**\   Adjusted for confounders
                                                                      (n NA)                                (n NA)                                 (1244/29,667)                                  (1326/30,813)                ^b,c^\                   
                                                                                                                                                                                                                               (0.80 to 1.03)           

  **Infant mortality**     Bhandari [@b2]          Cluster RCT        44.9/1000 live births\                43.9/1000 live births\                 65 per 1000 live births\                       69 per 1000 live births\     **Hazard ratio 0.85**\   Adjusted for confounders
                                                                      (n NA)                                (n NA)                                 (1925/29,667)                                  (2136/30,813)                ^b^\                     
                                                                                                                                                                                                                               (0.77 to 0.94)           

  **Child mortality**      Arifeen [@b1]^d^        Cluster RCT        43.0 per 1000 live births\            44.8 per 1000 live births(179/3996)    27.0 per 1000 live births\                     31.2 per 1000 live births\   **Risk ratio 0.87**\     No effect after exclusion of injuries^e^
                                                                      (144/3348)                                                                   (157/5815)                                     (221/7083)                   (0.66 to 1.14)           

                           Schellenberg [@b4]^f^   CBA                27.2 per 1000 child-years\            27.0 per 1000 child-years\             24.4 per 1000 child-years\                     28.2 per 1000 years\         **Risk ratio 0.87**\     No effect after adjustment
                                                                      (639/23,515)                          (242/8977)                             (1220/49,964)                                  (619/21,965)                 (0.72 to 1.05)           
  ------------------------ ----------------------- ------------------ ------------------------------------- -------------------------------------- ---------------------------------------------- ---------------------------- ------------------------ ------------------------------------------

**CBA**: controlled before-after study; **IMCI:** integrated management of childhood illness; **RCT:** randomised controlled trial

^a^Bhandari 2012: Fieldworkers not involved with IMNCI implementation visited households monthly to identify new pregnancies. Infants were visited at 1, 3, 6, 9, and 12 months to determine survival

^b^Bhandari 2012: Hazard ratio was calculated after adjustment for cluster design and potential confounders between groups (markers of poverty, literacy, access to services)

^c^Bhandari 2012: Although the overall effect was not statistically significant, a subgroup analysis found that a statistically significant reduction in neonatal mortality was significantly lower in the subgroup born at home (adjusted HR 0.80, 95% CI 0.68 to 0.93)

^d^Arifeen conducted a household census in 2000 and 2007 where the complete birth history of all ever married women between the age of 15 and 49 years was used to estimate yearly and 2 year mortality rates. The data pertains to mortality between day 7 and 5 years of life.

^e^After exclusion of deaths due to malformation and injury (causes not related to IMCI), no effect of IMCI was noted on mortality (data not available)

^f^This is the value adjusted for baseline differences in mortality. Unadjusted value is 4.2/1000 fewer deaths (95% CI -4.1 to 12.4). Mortality was slightly higher in the control group at baseline. Schellenberg study (Schellenberg [@b4])

Also estimated mortality difference after "ignoring the between district variation" as 13% lower mortality (95% CI 5% to 21% lower) (P value = 0.004); risk ratio 0.87 (95% CI 0.79 to 0.95)

###### 

Results: nutritional parameters

  ------------------------ ------------------------- ------------------ ---------------------- ----------------------- -------------- --------------
  **Parameter**            **Study**                 **Study design**   **Pre-intervention**   **Post-intervention**                  

  **IMCI**\                **Control**\              **IMCI**\          **Control**\                                                  
  **% (n/N)**              **% (n/N)**               **% (n/N)**        **% (n/N)**                                                   

  **Wasting**              Arifeen [@b1]^a^          Cluster RCT        21.5%\                 21.6%\                  12.6%\         14.3%\
                                                                        (74/346)               (95/439)                (89/706)       (101/709)

                           Schellenberg [@b4]^b^     CBA                12.57%\                10.5%\                  6.8%\          5.6%\
                                                                        (21/167)               (21/200)                (13/191)       (10/177)

                           Bhandari [@b2]            Cluster RCT                                                       16.6%\         14.3%\
                                                                                                                       (243/1461)     (202/1412)

  **Stunting**             Arifeen [@b1]^c^          Cluster RCT        63.1%\                 62.5%\                  50.4%\         57.1%\
                                                                        (334/530)              (432/692)               (599/1189)     (674/1180)

                           Schellenberg [@b4]^c,d^   CBA                59.7%\                 51.1%\                  42.6%\         40.0%\
                                                                        (297/497)              (247/483)               (249/585)      (191/477)

                           Bhandari [@b2]            Cluster RCT                                                       49.6%\         48.2%\
                                                                                                                       (725/1461)     (680/1412)

  **Low weight for age**   Schellenberg [@b4]^e^     CBA                30.6%\                 26.3%\                  23.4%\         19.5%\
                                                                        (290/947)              (238/905)               (234/1001)     (161/825)

  **HAZ score**\           Arifeen [@b1]             Cluster RCT        -2.35 (0.20)           -2.39 (0.33)            -2.01 (0.14)   -2.17 (0.20)
  **Mean (SD)**                                                                                                                       

  **WHZ score**\           Arifeen [@b1]             Cluster RCT        -1.18 (0.20)           -1.23 (0.19)            -0.77 (0.25)   -0.84 (0.14)
  **Mean (SD)**                                                                                                                       
  ------------------------ ------------------------- ------------------ ---------------------- ----------------------- -------------- --------------

**CBA:** controlled before-after; **HAZ:** height for age z-score; **IMCI:** integrated management of childhood illness; **RCT:** randomised controlled trial; **WHZ:** weight for age z-score

^a^WHZ ≤ 2 in children 0 to 23 months of age. Data from baseline and end surveys

^b^WHZ ≤ 2 in children 12 to 23 months of age. Data from baseline and end surveys

^c^HAZ ≤ 2 in children 24 to 59 months of age. Data from baseline and end surveys

^d^When expressed as mean haz scores, differential change between IMCI and comparison districts reached statistical significance (data not available/depicted)

^e^WAZ ≤ 2. Data from baseline and end surveys

###### 

Results: quality (facility level)

  ---------------------------------------------------- ----------------------- ---------------------- ----------------------- ------------- --------------
  **Outcome**                                          **Study**               **Pre-intervention**   **Post-intervention**                 

                                                                               **IMCI**\              **Control**\            **IMCI**\     **Control**\
                                                                               **% (n/N)**            **% (n/N)**             **% (n/N)**   **% (n/N)**

  **Index of integrated assessment (0 to 100)**        Arifeen [@b1]^a^        \-                     \-                      85.0%\        11.0%\
                                                                                                                              (150/176)     (15/132)

  **Correct management of all illness**                Arifeen [@b1]^a^        \-                     \-                      64.6%\        10.2%\
                                                                                                                              (111/172)     (13/131)

  **Children with dehydration correctly treated**      Arifeen [@b1]^a^        \-                     \-                      28.7%(1/4)    0.0%\
                                                                                                                                            (0/2)

                                                       Schellenberg [@b4]^b^   \-                     \-                      20.0%\        0.0%\
                                                                                                                              (1/5)         (0/3)

  **Child with pneumonia correctly treated**           Arifeen [@b1]^a^        \-                     \-                      80.8%\        3.4%\
                                                                                                                              (46/ 57)      (1/ 31)

                                                       Schellenberg [@b4]^b^   \-                     \-                      19.5%\        10.1%\
                                                                                                                              (45/231)      (19/188)

  **Child with anaemia correctly treated**             Arifeen [@b1]^a^        \-                     \-                      0.0%\         0.0%\
                                                                                                                              (3)           (5)

  **Child needing referral was referred**              Arifeen [@b1]^a^        \-                     \-                      35.7%\        25.0 %\
                                                                                                                              (2/6)         (1/4)

  **Children with fever treated with antimalarials**   Schellenberg [@b4]^b^   39.4%\                 44.5%\                  27.4%\        34.2%\
                                                                               (147/373)              (153/344)               (108/394)     (80/234)
  ---------------------------------------------------- ----------------------- ---------------------- ----------------------- ------------- --------------

**IMCI:** integrated management of childhood illness

^a^Data from health facility surveys done in 2003 and 2005 and estimates weighted by total number of sick children seen in facilities on survey days.

Baseline data collected in 2003, 1 year after initiation of facility-based IMCI. Indicators based on IMCI health facility survey guidelines

^b^Data from household surveys conducted in 1999 and 2002

###### 

Results: quality (prescribing by lay health care workers)

  ---------------------------------------------------------------- ----------------------- ------------------ ---------------------- ----------------------- -------------- --------------
  **Outcome**                                                      **Study**               **Study design**   **Pre-Intervention**   **Post-intervention**                  

  **IMCI**\                                                        **Control**\            **IMCI**\          **Control**\                                                  
  **% (n/N)**                                                      **% (n/N)**             **% (n/N)**        **% (n/N)**                                                   

  **Children with diarrhoea treated with ORS**                     Arifeen [@b1]           Cluster RCT        \-                     \-                      48%\           30%\
                                                                                                                                                             (60/125)       (32/108)

                                                                   Schellenberg [@b4]^a^   CBA                24.7%\                 10.4%\                  25.3%\         19.0%\
                                                                                                              (21/85)                (10/96)                 (23/91)        (15/79)

  **Change in % of children with diarrhoea treated with ORS**      Mohan [@b3]^b^          CBA                \-                     \-                      1.6%           0.7%

  **Children with suspected pneumonia treated with antibiotics**   Arifeen [@b1]           Cluster RCT        \-                     \-                      52%(156/300)   48%(167/348)
  ---------------------------------------------------------------- ----------------------- ------------------ ---------------------- ----------------------- -------------- --------------

**CBA:** controlled before-after study; **IMCI:** integrated management of childhood illness; **ORS:** oral rehydration salts; **RCT:** randomised controlled trial

^a^Proportion of children ill in the last 2 weeks of the survey at baseline and at end of study period who were taken to an appropriate health care provider

^b^Data collected from 2 rounds of district-level health surveys in districts that implemented IMCI in 2005 and in control districts matched for IMR and proportion of scheduled castes and scheduled tribes. Weighted average of percentage change in coverage levels calculated for the 2 groups

###### 

Results: coverage (vaccines)

  ---------------------------------------- ----------------------- ------------------ ---------------------- ----------------------- ------------ ------------
  **Parameter**                            **Study**               **Study design**   **Pre-intervention**   **Post-intervention**                

  **IMCI**\                                **Control**\            **IMCI**\          **Control**\                                                
  **% (n/N)**                              **% (n/N)**             **% (n/N)**        **% (n/N)**                                                 

  **Measles vaccine coverage**             Arifeen [@b1]^a,b^      Cluster RCT        36.9%\                 32.2%\                  52.7%\       57.4%\
                                                                                      (124/335)              (131/406)               (219/416)    (239/417)

                                           Bhandari [@b2]          Cluster RCT                                                       11.1%\       16.8%\
                                                                                                                                     (226/2045)   (339/2017)

                                           Schellenberg [@b4]^c^   CBA                88.3%\                 89.4%\                  88.2%\       93.0%\
                                                                                      (159/180)              (194/217)               (180/204)    (172/185)

  **Change in coverage of all vaccines**   Mohan [@b3]^d,e^        CBA                \-                     \-                      3.8%         11.1%

  **DPT3 vaccine coverage**                Bhandari [@b2]          Cluster RCT                                                       15.6%\       21.2%\
                                                                                                                                     (318/2045)   (427/2017)

                                           Schellenberg [@b4]^c^   CBA                87.2%\                 85.3%\                  81.9%\       95.1%\
                                                                                      (157/180)              (185/217)               (167/204)    (176/185)

  **Vitamin A supplementation coverage**   Arifeen [@b1]^a^        Cluster RCT        82.1%\                 74.4%\                  85.3%\       91.7%\
                                                                                      (272/331)              (301/405)               (355/416)    (381/415)

                                           Schellenberg [@b4]^c^   CBA                12.9%\                 13.5%\                  77%\         76.8%\
                                                                                      (25/194)               (28/208)                (154/200)    (142/185)
  ---------------------------------------- ----------------------- ------------------ ---------------------- ----------------------- ------------ ------------

**CBA:** controlled before-after study; **DPT:** Diphtheria-Pertussis-Tetanus; **IMCI:** integrated management of childhood illness; **RCT:** randomised controlled trial

^a^Data available from 6 monthly household surveys at baseline and at end

^b^Data collected from vaccination cards

^c^Data collected through information or registration during household surveys

^d^Data collected from 2 rounds of district-level health surveys in districts that implemented IMCI in 2005 and in control districts matched for IMR and proportion of scheduled castes and scheduled tribes. Weighted average of percentage change in coverage levels calculated for the 2 groups

^e^Change in proportion of children fully immunized

###### 

Results: coverage (care seeking behavior)

  ------------------------------------------------- ----------------------- ------------------ ---------------------- ----------------------- ------------ ------------
  **Outcome**                                       **Study**               **Study design**   **Pre-intervention**   **Post-intervention**                

  **IMCI**\                                         **Control**\            **IMCI**\          **Control**\                                                
  **% (n/N)**                                       **% (n/N)**             **% (n/N)**        **% (n/N)**                                                 

  **Change (%) children with ARI seeking care**     Mohan [@b3]^a^          CBA                NA                     NA                      +6.7%        -11.1%

  **Appropriate care seeking**                      Bhandari [@b2]^b^       Cluster RCT        NA                     NA                      46.9%\       29.5%\
                                                                                                                                              (474/1010)   (374/1269)

                                                    Arifeen [@b1]^c^        Cluster RCT        6%\                    4%\                     24%\         5%\
                                                                                               (18/302)               14/360)                 (111/462)    (24/483)

                                                    Schellenberg [@b4]^d^   CBA                41.2%\                 42.2%\                  38.2%\       32.3%\
                                                                                               211/512)               (212/502)               (203/531)    (138/427)

  **Care seeking for children with danger signs**   Schellenberg [@b4]^d^   CBA                53.1%\                 68%\                    54.9%\       43.4%\
                                                                                               (86/162)               (100/147)               (78/142)     (49/113)
  ------------------------------------------------- ----------------------- ------------------ ---------------------- ----------------------- ------------ ------------

**ARI:** acute respiratory infection; **CBA:** controlled before-after study; **IMCI:** integrated management of childhood illness; **IMR:** infant mortality rate; **RCT:** randomised controlled trial

^a^Data collected from 2 rounds of district-level health surveys in districts that implemented IMCI in 2005 and in control districts matched for IMR and proportion of scheduled castes and scheduled tribes. Weighted average of percentage change in coverage levels calculated for the 2 groups

^b^Proportion of neonates with danger signs who were taken to an appropriate health care provider (physician in government or private health facility or community health care worker)

^c^Proportion of children ill in the last 2 weeks of the survey at baseline and at end of study period who were taken to an appropriate health care provider

^d^Data from household surveys conducted in 1999 and 2002

###### 

Results: coverage (breast feeding and other child rearing practices)

  ------------------------------------------ ----------------------- ------------------ ---------------------- ----------------------- -------------- --------------
  **Practice**                               **Study**               **Study design**   **Pre-intervention**   **Post-intervention**                  

  **IMCI**\                                  **Control**\            **IMCI**\          **Control**\                                                  
  **% (n/N)**                                **% (n/N)**             **% (n/N)**        **% (n/N)**                                                   

  **Exclusive breast feeding**               Bhandari [@b2]^a,b^     Cluster RCT        \-                     \-                      77.6%\         37.3%\
                                                                                                                                       (4811/6204)    (2300/6163)

                                             Arifeen [@b1]^c^        Cluster RCT        56.3%\                 56.2%\                  75.5%\         65.3%\
                                                                                        (825/1466)             (1021/1817)             (1024/1356)    (1149/1759)

                                             Schellenberg [@b4]^d^   CBA                20.7%\                 26.1%\                  22.7%\         32.1%\
                                                                                        (23/111)               (18/69)                 (15/66)        (17/53)

                                             Mohan [@b3]^e^          CBA                \-                     \-                      30.0%          24.3%

  **Complementary feeding**                  Arifeen [@b1]^f^        Cluster RCT        60.4%\                 52.8%\                  67.6%\         57.2%\
                                                                                        (734/1216)             (873/1653)              (792/1172)     (783/1369)

                                             Schellenberg [@b4]^f^   CBA                89.9%\                 95.9%\                  98.8%\         98.7%\
                                                                                        (71/79)                (70/73)                 (80/81)        (74/75)

                                             Bhandari [@b2]^g^       Cluster RCT                                                       33.6%\         37.6%\
                                                                                                                                       (687/2045)     (759/2017)

  **Pre-lacteal feeds not given**            Bhandari [@b2]^a^       Cluster RCT        \-                     \-                      80.2%\         32.6%\
                                                                                                                                       (4977/6204)    (2006/6163)

  **Breast feeding initiated**\              Bhandari [@b2]^a^       Cluster RCT        \-                     \-                      40.7%\         11.2%\
  **within 1 hour of birth**                                                                                                           (2527/6204)    (689/6163)

                                             Mohan [@b3]^e^          CBA                \-                     \-                      18.1%          13.6%

  **Newborn care practices**\                Bhandari [@b2]^a^       Cluster RCT        \-                     \-                      84.5%\         46.2%\
  **Delayed bathing**                                                                                                                  (5243/6204)    (2848/6163)

  **Cord care**                              Bhandari [@b2]^a,h^     Cluster RCT                                                       84.1%\         39.5%\
                                                                                                                                       (5219/6204)    (2436/6163)

  **Appropriate clothing**\                  Bhandari [@b2]^a^       Cluster RCT                                                       97.5%\         97.9%\
  **Skin-to-skin contact on day of birth**                                                                                             (6048/6204)\   (6036/6163)\
                                                                                                                                       1.7%\          0.0%\
                                                                                                                                       (108/6204)     (2/6163)
  ------------------------------------------ ----------------------- ------------------ ---------------------- ----------------------- -------------- --------------

**CBA:** controlled before-after study; **IMCI:** integrated management of childhood illness; **RCT:** randomised controlled trial

^a^A separate team of research assistants interviewed a randomly selected subset of mothers at 29 days to ascertain newborn care practices

^b^Exclusive breast feeding at 4 weeks of life

^c^Children \< 6 months exclusively breast feeding. Data from baseline and end population surveys

^d^Children younger than 4 months exclusively breast fed

^e^Data collected from 2 rounds of district-level health surveys in districts that implemented IMCI in 2005 and in control districts matched for IMR and proportion of scheduled castes and scheduled tribes. Weighted average of percentage change in coverage levels calculated for the 2 groups

^f^Children aged 6 to 9 months receiving both breast feeding and complementary food. Data from baseline and end population surveys

^g^Infants who received solid, semi solid, or soft foods in previous 24 hours and started complementary feeding between 6 and 8 months of age

^h^Nothing or Gentian Violet applied to the cord

Appendices
==========

Appendix 1. Search log and Search strategy for Identification of trials from various databases {#sec1}
----------------------------------------------------------------------------------------------

  ------------------------------------------------------------------------------- ------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------- ------
  Database                                                                        Date Searched      Strategy                                                                                                                                              Hits
  The Cochrane Central Register of Controlled Trials (CENTRAL)                    30 June 2015       (\"IMCI\") OR (\"IMNCI\") OR (\"integrated management of childhood illness\") OR (\"integrated management of childhood illnesses\") in All fields     28
  EMBASE, Ovid                                                                    30 June 2015       (\"IMCI\") OR (\"IMNCI\") OR (\"integrated management of childhood illness\") OR (\"integrated management of childhood illnesses\") in All fields     468
  CINAHL Plus, EbscoHost                                                          30 June 2015       (\"IMCI\") OR (\"IMNCI\") OR (\"integrated management of childhood illness\") OR (\"integrated management of childhood illnesses\") in All fields     375
  LILACS, VHL                                                                     30 June 2015       (\"IMCI\") OR (\"IMNCI\") OR (\"integrated management of childhood illness\") OR (\"integrated management of childhood illnesseses\") in All fields   198
  WHOLIS, WHO                                                                     30 June 2015       (\"IMCI\") OR (\"IMNCI\") OR (\"integrated management of childhood illness\") OR (\"integrated management of childhood illnesseses\") in All fields   58
  POPLINE                                                                         30 June 2015       (\"IMCI\") OR (\"IMNCI\") in All fields                                                                                                               427
  Science Citation Index and Social Sciences Citation Index, ISI Web of Science   30 June 2015       (\"IMCI\") OR (\"IMNCI\") OR (\"integrated management of childhood illness\") OR (\"integrated management of childhood illnesses\") in All fields     544
  Global Health, OvidSP                                                           08 May 2015        (IMCI or IMNCI or integrated management of childhood illness\*).af.                                                                                   359
  Health Management, ProQuest                                                     17 December 2012   (\"IMCI\") OR (\"IMNCI\") OR (\"integrated management of childhood illness\") OR (\"integrated management of childhood illnesseses\") in All fields   155
  MEDLINE, Ovid                                                                   30 June 2015       (\"IMCI\") OR (\"IMNCI\") OR (\"integrated management of childhood illness\") OR (\"integrated management of childhood illnesseses\") in All fields   381
  ------------------------------------------------------------------------------- ------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------- ------
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Differences between protocol and review
=======================================

*\"If there are sufficient studies, we also summarised trials with a concurrent comparison group (no IMCI intervention) and adjustment for baseline characteristics and confounders\" -* as we found insufficient studies, we did not carry out this analysis. Two outcomes specified in the protocol were dropped from the review: illness episodes of diarrhoea and pneumonia, as it would be unusual for curative services to reduce the incidence of disease. One study also reported on other newborn care practices, which we did not anticipate, and we describe these results under \"coverage.\"

We specified measures of mortality (neonatal, infant, and under-five mortality) rates and reported on these. We added a measure called \"any mortality\" and carried out meta-analysis on the study that reported infant mortality with the study that reported child mortality.
